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Abstract 
 
SYNAPTIC EFFECTS OF ETHANOL ON THE AGRANULAR 
INSULAR CORTEX 
 
Joel E. Shillinglaw, Ph.D. 
The University of Texas at Austin, 2019 
 
Supervisor:  Rueben A. Gonzales 
 
The purpose of this study was to provide the first examination of whether the 
agranular insular cortex (AIC) is a target for the actions of ethanol.  Initially, we wished to 
determine whether basic excitatory and inhibitory synaptic transmission in the AIC are 
sensitive to acute ethanol.  Therefore, we collected brain slices from ethanol-naïve adult 
male mice, obtained whole-cell recording configuration in layer 2/3 AIC pyramidal 
neurons, and bath-applied ethanol at pharmacologically relevant concentrations during 
electrophysiological assays of glutamatergic and γ-amino-butyric acid (GABA)ergic 
synaptic transmission and plasticity.  We found that ethanol inhibited electrically evoked 
N-methyl-D-aspartate receptor (NMDAR)-mediated excitatory postsynaptic currents 
(EPSCs) in a concentration-related fashion, and had little effect on other 
electrophysiological parameters of glutamatergic and (GABA)ergic synaptic transmission.  
Synaptic conditioning (low-frequency stimulation for 15 min at 1 Hz) induced a form of 
long-term depression (LTD) that was inhibited by a nonselective NMDAR antagonist (DL-
2-amino-5-phosphonovaleric acid), and also by acute, intoxicating concentrations of 
ethanol.  We then wished to determine whether NMDAR-dependent LTD in the AIC is 
 vii 
sensitive to chronic ethanol. We utilized the Becker-Lopez chronic intermittent ethanol 
(CIE) exposure model to model chronic ethanol experience, and found that CIE vapor 
exposure disrupted the ability to induce NMDAR-dependent LTD in the AIC.  Then, we 
wished to determine whether NMDAR-dependent LTD and other glutamatergic synaptic 
properties in the AIC are differentially modulated by conditions that promote aspects of 
alcohol use disorder (AUD) relative to conditions that do not.  Therefore, groups of 
ethanol-drinking mice underwent either extended CIE (Drinking + CIE) or air (Drinking + 
Air) to generate AUD-like and non AUD-like phenotypes, respectively, before undergoing 
electrophysiological recordings testing for LTD and other glutamatergic synaptic 
properties.  Drinking + CIE and Drinking + Air groups no longer displayed NMDAR-
dependent LTD, but Drinking + CIE groups displayed a reduced NMDA/AMPA ratio 
relative to Drinking + Air groups.  To verify the reduction in NMDA/AMPA ratio between 
Drinking + CIE and Drinking + Air groups, as well as determine whether modest amounts 
of ethanol drinking alter NMDA/AMPA ratio, we replicated the experiment with an 
additional ethanol-naïve handling control group.  We found that ethanol drinking alone 
reduces NMDA/AMPA ratio relative to ethanol naïve animals.  Finally, to verify whether 
AIC NMDAR-dependent LTD was not an age-dependent phenomenon, we tested for the 
presence of LTD in an additional ethanol-naïve group age-matched to the Drinking + CIE 
and Drinking + Air groups (≥14 weeks).  We no longer observed the presence of LTD.  
These data indicate that glutamatergic transmission is sensitive to acute and chronic ethanol 
in AIC 2/3 pyramidal neurons, and that even moderate, non AUD-like ethanol drinking 
may alter age-dependent glutamatergic synaptic plasticity mechanisms.   
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CHAPTER 1:  
BACKGROUND 
 
ALCOHOL 
An alcohol is any carbon-based compound that contains a hydroxyl (-OH) group.  
Ethanol is the two-carbon alcohol that is used for human consumption.  Ethanol is produced 
via fermentation; any type of carbohydrate can be converted into glucose which can then 
be fermented with yeast to produce ethanol and carbon dioxide.  Ethanol has been produced 
for human consumption for thousands of years, and its production has been considered an 
indicator of the transition from hunter-gatherer to agricultural societies (Chrzan, 2013).  
Historically, ethanol has been consumed for its nutritional, medicinal, spiritual, and 
pharmacological effects.  
 
ALCOHOL USE  
Drinking ethanol is ubiquitous to our society as it is interwoven in our culture and 
involved in several aspects of life.  In the United States, 82% of people aged 12 and older 
were estimated to have ever consumed ethanol, and 65.9% of those had used alcohol in the 
past year (Koob et al., 2014).  Moreover, more than 50% of Americans over the age of 18 
consume ethanol regularly (CDC, 2012).  The large majority of drinkers consume ethanol 
for its positive subjective effects, including anxiolysis (relief from anxiety), mild euphoria, 
social disinhibition, and tension reduction.  This general enhancement in emotional state 
due to the pharmacological effects of ethanol increases the likelihood of future ethanol 
consumption, a psychological concept called positive reinforcement.  The positive 
reinforcing aspects of ethanol consumption are the motivating factors for initial ethanol 
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use, as ethanol consumption is generally accepted to begin in a social environment for the 
pleasurable effects of drinking. 
However, a minority of the individuals who drink ethanol escalate their 
consumption, and become preoccupied with drinking to a level that is detrimental to their 
health.  The terms for this condition have evolved over time, and have included alcoholism, 
alcohol abuse, and alcohol dependence.  However, the most recent iteration of the 
Diagnostic and Statistical Manual of Mental Disorders, the DSM-V (2013), denotes this 
condition as Alcohol Use Disorder (AUD).  Once an individual has an AUD, the 
motivational locus of control behind ethanol drinking may have shifted.  While ethanol 
was originally consumed in a controlled fashion for its positively reinforcing, pleasurable 
effects, those individuals with AUD now likely consume ethanol in an uncontrolled fashion 
in order to alleviate negative emotional states, such as anxiety and irritability.  Thus, 
individuals with AUD suffer from a life of preoccupation with and recovery from ethanol 
drinking and its associated detrimental health effects. 
 
ALCOHOL USE DISORDER 
The general preoccupation with ethanol consumption characteristic of AUD is 
exemplified in the DSM-V (2013).  The diagnostic criterion for AUD is the following list:  
1) Excessive use for longer than intended, 2) unsuccessful efforts to reduce use, 3) 
significant time allotted to use or recovery from ethanol use, 4) craving, 5) use or 
recovering from use caused home, job, or school problems, 6) use despite it causing trouble 
with family or friends, 7) reducing social, occupational, or recreational activities to use, 8) 
use in situations in which it is physically hazardous, 9) use despite its having depressing or 
anxiogenic (anxiety-producing) effects or adding to other health problems, 10) escalated 
use to obtain desired effect, and 11) withdrawal symptoms in the absence of use. This 11-
question inventory can be collapsed into the three hallmarks of substance use disorder:  1) 
Compulsion to seek and take a drug, 2) loss of control in limiting intake, and 3) the 
emergence of a negative emotional state (e.g. anxiety, irritability) when access to the drug 
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is prevented.  As a spectrum disorder, the degree of severity is contingent upon the number 
of questionnaire items to which an individual responds positively.  The presence of 2-3 of 
the criteria indicate a mild AUD, the presence of 4-5 of the criteria indicate a moderate 
AUD, and the presence of 6 or more of the 11 criteria indicate a severe AUD. 
 
PREVALENCE AND COST OF ALCOHOL USE DISORDER 
AUD is a prevalent and costly health problem.  Of the 170.4 million of the United 
States population (aged 12 and older) to have consumed ethanol in the past year, 16.7 
million, or 9.8% met the diagnostic criteria for an AUD (Koob et al., 2014).  This problem 
is stratified around the late-adolescent and early-adulthood periods, as approximately 1/3 
of 18-24 year olds in the United States meet the criteria for AUD (National Institute on 
Alcohol Abuse and Alcoholism [NIAAA], 2005).  Complications from excessive ethanol 
consumption were responsible for 1 in 10 deaths among working-age adults between 2006 
and 2010, and cost the United States an estimated $249 billion in 2010 (Sacks et al., 2015).  
An analysis of the “actual” causes of death, which investigated the nongenetic modifiable 
behavioral factors that contributed to death in the United States in 1990 & 2000, showed 
ethanol consumption was the third leading actual cause of death, behind only (1) tobacco 
use and (2) poor diet and physical inactivity (Mokdad et al., 2004).  These included ethanol-
related crashes, various types of cancer linked to ethanol use, cardiovascular complications 
such as stroke and hypertensive heart disease, and chronic liver disease and cirrhosis.  The 
economic impact of AUD is substantial, and a global issue.  An analysis which investigated 
the risk factors for loss of years to disease and disability in 2012 found that ethanol use is 
the third-largest risk factor worldwide, behind only (1) childhood underweight and (2) 
unsafe sex.  This investigation additionally found that ethanol use is responsible for 2.5 
million deaths per year, which is almost 4% of all global deaths (World Health 
Organization., 2009). 
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CANONICAL ADDICTION MOTIVATIONAL FRAMEWORK 
The development of AUDs (and other substance use disorders) is accepted to occur 
via neurobiological changes in brain regions and brain circuits implicated in motivational 
processes (Koob et al., 2014).  Therefore, AUD can be thought of as disrupted motivational 
processing for ethanol.  The motivational changes characteristic of AUD develop over the 
course of the three stage model of ethanol use leading to AUD: 1) Binge/Intoxication, 2) 
Withdrawal/Negative Affect, and 3) Preoccupation/Anticipation (Koob et al., 2014).  The 
neuroadaptations which occur at each stage in the model increase the likelihood an AUD, 
and through repeated cycles this three-part process ultimately produce an AUD. 
 In the initial, Binge/Intoxication stage, the positively reinforcing pharmacological 
effects of ethanol leads the drinker to consume ethanol to levels of intoxication.  Once 
intoxication occurs, the removal of ethanol from the brain regions and circuits implicated 
in the positive reinforcing effects of ethanol and motivational valence produces the 
Withdrawal/Negative Affect stage.  At this stage, changes occur to motivational systems, 
and therefore symptoms which oppose the acute positively reinforcing effects of ethanol 
occur.  For example, the socially disinhibiting, tension reducing effects of acute ethanol 
are now typically replaced with general irritability and anxiety.  Ethanol-withdrawal 
induced anxiety is a common symptom following a binge exposure to ethanol (Koob et al., 
2014).  Following the Withdrawal/Negative Affect stage, the Preoccupation/Anticipation 
stage of AUD occurs, in which obtaining and drinking ethanol gains priority and the 
individual becomes more sensitive to conditioning effects associated with ethanol use and 
availability.  It is important to note that this model for AUD is imperfect: Although history 
of ethanol exposure is a contributing component of AUD, the development of AUDs are 
accepted to occur due to a myriad of factors including but not limited to social, 
environmental, genetic, and ethanol exposure history (Koob et al., 2014).  Nevertheless, 
several repeated cycles of the aforementioned 3-stage model produce an AUD in a minority 
of individuals in which healthy functioning is affected by the preoccupation with and use 
of ethanol. 
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ANIMAL MODELS OF ALCOHOL USE DISORDER  
Psychiatric disorders, on the whole, are complex, multidimensional deviations of 
healthy functioning which are constantly evolving and contain various subtypes and 
diverse etiology (Edwards and Koob, 2003).  It is therefore thought that using an animal 
model to generate the complete syndrome of any psychiatric disorder is highly unlikely, if 
not impossible.  Moreover, animal models rely only on an animal’s behavior to inform us 
of its internal state.  Since the characteristics of many psychiatric disorders, including 
AUD, involve complex internal states that are often in disagreement with external behavior 
(i.e. an individual with AUD who does not drink despite cravings), animal models have 
limited utility investigating the subjective aspects of AUD (Naqvi and Bechara, 2010).  
Nonetheless, addiction scientists can generate observable aspects of AUD in animals, 
which can then be used for neurobiological investigation. 
There are several animal models which have construct validity with the 3 stages of 
the addiction cycle (Binge/Intoxication, Withdrawal/Negative Affect, 
Preoccupation/Anticipation). These models have proven not only necessary for a 
comprehensive understanding of the addiction cycle, but also useful for screening potential 
treatment compounds for individuals with AUD.  In particular, rodent models of the 
binge/intoxication stage have proven to have excellent predictive validity to ethanol intake 
in humans.  Multiple FDA-approved medications for AUD were developed by using animal 
models before being successfully implemented in humans (Spanagel, 2017).   
 Historically, animal researchers have focused their investigations on the initial, 
positively reinforced aspects of ethanol drinking and its neurobiological substrates.  
Although investigations of this field have proven to be of vital importance for developing 
treatments, positively reinforced drinking mechanisms do not model all aspects of the 
pathology of AUD.  Since the overwhelming majority (≈ 90%) of alcohol drinkers do not 
have an AUD, it is clear that understanding only the positively reinforcing effects of initial 
ethanol use has limited utility.  A more precise way to parse out AUD-like rather than 
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initial ethanol consumption is to investigate the neurobiological and behavioral differences 
between animals that drink ethanol that display aspects of AUD from animals that drink 
ethanol and do not display aspects of AUD.  One such way to do this is to use the Becker-
Lopez chronic intermittent ethanol (CIE) two-bottle choice (2BC) exposure model (Becker 
and Lopez 2004; Griffin, 2014; Griffin et al., 2009; Renteria et al., 2017).  
The Becker-Lopez CIE 2BC exposure model is a mouse model of AUD that uses 
bouts of passive ethanol exposure followed by withdrawal to increase volitional ethanol 
drinking.  In this model, mice initially drink ethanol for several weeks via 2BC drinking in 
which one bottle of contains water, and the other bottler contains 15% ethanol (v/v).  Then, 
mice are then treated with bouts of chronic intermittent ethanol (CIE) vapor targeting blood 
ethanol concentrations (≈35-45 mM).  Each bout contains a 4-day period during which an 
animal is treated with ethanol vapor for 16 hours per day followed by an 8 hour period of 
withdrawal. Following each bout mice undergo a 3 day period of withdrawal.   
Because of the long duration of ethanol exposure, physiological processes occur to 
counteract the effects of ethanol and maintain homeostasis.  As a result of these 
physiological processes, a new homeostatic set point emerges (allostasis), such that 
removal of ethanol is now a disruptive event.  Once allostasis occurs, an animal is now 
dependent on ethanol for normal physiological functioning, and therefore increases its 
volitional ethanol intake following withdrawal.  Therefore, the Becker-Lopez CIE/2BC 
model allows us to model two hallmarks of AUD:  1) Escalated intake, and 2) Withdrawal 
symptoms after ceasing use.  This validated model of increased volitional ethanol drinking 
permits researchers to investigate neuroadaptations as alcohol drinking becomes dependent 
(Becker and Lopez, 2004; Renteria et al., 2017; Griffin et al., 2009).  Importantly, the 
control group in this study identically drinks ethanol via 2BC drinking, but is not treated 
with CIE and therefore does not undergo withdrawal and develop dependence.  Therefore, 
this control group of animals does not typically display escalated intake or withdrawal 
symptoms after ceasing ethanol use, and can therefore be thought of as a model of non 
AUD-like ethanol consumption.     
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MEDICATION OPTIONS 
A hallmark of SUD and AUD is their chronically relapsing nature; 90% of 
individuals with AUD will begin drinking ethanol again to intoxicating levels following an 
extended period of abstinence (National Institute on Alcohol Abuse and Alcoholism 
[NIAAA], 1989).  Current pharmacological and behavioral treatments for AUDs have 
achieved only moderate success decreasing the vulnerability to relapse in individuals with 
AUD in abstinence (Scofield et al., 2016).  Therefore, a more comprehensive 
understanding of the neuroadaptations produced by chronic ethanol exposure in unexplored 
brain regions of addiction-relevance might yield improved targets for pharmacotherapy.  
Because the addiction cycle is composed of the 3 stage cycles, it is now even suggested 
that it is possible to use different drugs to treat different aspects of the addiction cycle 
(Koob et al., 2014).  There are currently three medications approved by the FDA to treat 
AUD: disulfiram, acamprosate, and naltrexone.   
Disulfiram (Antabuse) is an acetaldehyde dehydrogenase inhibitor that is targeted 
to decrease alcohol drinking and relapse via an aversion reaction.  Ethanol is metabolized 
in the liver mainly via an oxidation pathway; alcohol is oxidized into acetaldehyde thru 
alcohol dehydrogenase.  Then, acetaldehyde dehydrogenase oxidizes acetaldehyde into 
acetic acid, and then into water and carbon dioxide.  Disulfiram’s inhibition of 
acetaldehyde dehydrogenase therefore causes a build-up of acetaldehyde in the blood.  
High blood levels of acetaldehyde cause an aversive, flushing reaction along with 
tachycardia, nausea, and vomiting.  Together these symptoms make ethanol consumption 
aversive, which therefore limits drinking.  Although disulfiram has efficacy limiting 
ethanol consumption in individuals with AUD, there are major issues with compliance.  
Individuals with AUD, by definition, have a compulsive preoccupation with experiencing 
the effects of ethanol.  Since Disulfiram limits this experience, individuals with AUD are 
likely to stop taking their medication.  There have been attempts to enhance compliance 
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with via the development of slow-releasing disulfiram implants (Allen & Litten; 1992).  
However, these have proven only modestly effective. 
Acamprosate (Campral) is used in AUD for relapse prevention in abstinent 
individuals with AUD.  It has shown to be decrease the risk to relapse, but not affect the 
craving for ethanol in individuals with AUD (Umhau et al., 2011; Spanagel, 2014).  The 
exact molecular mechanism responsible for the actions of acamprosate has still not yet been 
determined.  It was originally hypothesized to normalize the excitatory and inhibitory 
signaling imbalances in the brain caused by chronic ethanol via its modulatory actions on 
the N-methyl-D-aspartate (NMDA) receptor or through action on metabotropic glutamate 
receptors (mGluRs) (Spanagel and Vengeliene, 2013; De Witte et al., 2005; Mann et al, 
2008; Rammes et al, 2001; Harris et al., 2002).  However, there has been some additional 
recent work showing that acamprosate works via normalizing calcium homeostasis 
(Spanagel et al., 2014).  Overall, acamprosate has proven to be a moderately effective 
treatment strategy for maintaining abstinence with individuals with (Rösner et al., 2010). 
Naltrexone is used in AUD for relapse prevention via reducing ethanol craving.  
Naltrexone is a µ opioid receptor antagonist that has been shown to reduce the positively 
reinforcing properties of alcohol in several animal models of ethanol drinking (Koob et al.,  
2014).  Although data from the animal laboratory directly indicates that naltrexone reduces 
ethanol drinking by its actions on ethanol reward, it has shown efficacy in reducing alcohol 
craving components of AUD (Volpicelli et al., 1992).  It has been shown that naltrexone is 
useful in reducing alcohol craving and the number of heavy drinking days relative to 
placebo in those individuals with AUD (Streeton and Whelan, 2001). 
In addition to the three FDA-approved medications to treat AUD, there are several 
FDA-approved medications for other conditions that have shown efficacy reducing ethanol 
drinking in animal models of AUD.  These medications are approved for a variety of 
different health issues, including but not limited to SUD (varenicline), nausea/vomiting 
(ondansetron), seizure disorders (gabapentin, topiramate), muscle spasms (baclofen), and 
even metabolic syndrome (fenofibrate).  Clinical trials for these drugs are necessary, and 
in some cases, ongoing.  
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Finally, while the FDA-approved medications for AUD at present have limited 
efficacy, a larger component hindering successful treatment of individuals with AUD are 
factors inhibiting treatment-seeking.  Only approximately 20% of people with AUDs seek 
any kind of treatment (Cohen et al., 2007; Dawson et al., 2006).  This is thought to be 
attributed to the public perception and stigma attached to AUD relative to other mental 
illnesses, and doubts of the efficacy of treatment (Schomerus et al., 2011; Saunders et al., 
2006).  Moreover, some individuals with AUD have reservations about complete 
abstinence as the recovery goal, which many find neither feasible nor desirable (Copeland, 
1997).   Even more compelling is the fact that the current FDA-approved medications for 
AUD are prescribed in less than 9% of individuals who report needing help with an alcohol 
problem (Kranzler and Soyka, 2018).  This is thought to occur because of the historically 
high proportion of treatment-seeking individuals do so via community-based addiction 
treatment centers which either have a lack of knowledge about AUD medications or 
concerns of their modest effects (Weisner et al., 1995; Cohen et al., 2007). Taken together, 
basic neurobiological research is needed to understand the pathology of AUD and screen 
potential treatment compounds; however, approaches to increase treatment seeking and 
education of addiction treatment centers are likely more immediately beneficial to 
improving clinical outcomes.   
 
INSULAR CORTEX AND ADDICTION 
The insular cortex (INS) is a cortical brain region composed of three structurally 
and functionally distinct subregions arranged posterior to anterior: the granular insular 
cortex (GIC), the dysgranular insular cortex (DIC), and the agranular insular cortex (AIC) 
(Figure 1; Morel et al., 2013).  Sensory information from the viscera is transmitted to the 
GIC via a spinothalamic pathway via reciprocal connections with thalamic nuclei (Craig, 
2002).  Then, in a process called interoception, this information is relayed anteriorly and 
ventrally into DIC, and then into the AIC, which is considered the interoceptive hub.  Thus, 
the INS integrates internal information about the physiological condition of bodily tissues 
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such as temperature, touch quality, urinary bladder and stomach distension, and sends this 
information to cortical areas of conscious thought so that an organism may make the 
appropriate decisions to ensure homeostasis (Craig, 2002; Craig, 2009).  As an 
interoceptive brain region, the INS has major functions in the learning and experiencing of 
body-induced internal states such as awareness, taste memory, and pain perception (Brooks 
et al., 2005; Craig et al., 2000; Zhuo, 2008; Henderson et al., 2007). 
 
 
Figure 1: Diagram of the insular cortex 
 
 
The insular cortex, its subdivisions and major inputs/outputs.  Reproduced under the 
creative commons license from Naqvi et al. Ann N Y Acad Sci 1316 (2014) 53-70.  
 
INSULAR CORTEX AND ADDICTION: HUMAN STUDIES 
Research in humans indicates that the INS and maladaptive interoceptive 
processing are involved in conscious craving and potentially relapse components of 
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addiction; however, the specific role of the INS in these processes has not yet been clearly 
delineated.  The seminal study investigating the role of the INS in addiction suggests the 
INS mediates drug craving; smokers with INS damage underwent a “disruption” of 
cigarette smoking, in which they lost the subjective urges to smoke (Figure 2; Naqvi et al., 
2007).  Additional investigations of INS damage and cigarette smoking behavior have 
largely corroborated these findings, indicating a clear role for INS functioning in the 
maintenance of addiction to cigarette smoking (Suner-Soler et al., 2012; Abdolahi et al., 
2015; Gaznick et al., 2014; Abdolahi et al., 2017).  Several functional imaging studies 
support this “urge” hypothesis; human addicts in withdrawal displayed a positive 
correlation between INS activity and subjective drug urges when exposed to drug cues.  
Importantly, this relationship was observed across several drugs of abuse, and largely not 
observed in recreational drug users (Table 1; Naqvi and Bechara, 2010). 
These data suggest that INS neural networks sensitize during the development of 
addiction to mediate drug craving (Droutman et al., 2015).  From these studies, amongst 
others, Naqvi and Bechara (2010) have created a working model for the INS and drug 
addiction. They suggest that after long term drug use, environmental cues originally paired 
with drug use activate interoceptive memories of the bodily effects of drugs in the INS.  
These interoceptive memories are processed from the INS to other cortical regions such as 
the anterior cingulate cortex and are thought to contribute to the feeling of conscious urges 
to take drugs.  From this perspective, INS activity is an integrator between the bodily 
effects of drugs and environmental cues and plays a role in the conscious perception of 
drug craving. 
  Conversely, there are other human data which contradicts this model.  Imaging 
studies have shown reduced gray matter in the INS in drug users, and reduced INS activity 
in decision-making tasks in drug users predicts relapse to methamphetamine use 
(Droutman et al., 2015).   This data is mirrored by the alcohol research community.  
Interoceptive awareness, which has been taken to indicate healthy INS functioning, has 
been shown to be reduced in individuals with AUD relative to individuals without AUD 
(Ateş Çöl et al., 2016).  Moreover, this investigation found an inverse relationship between 
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interoceptive awareness and ethanol craving.  These latter findings indicate that that INS 
activity protects against drug relapse.  Nevertheless, on the whole, there exists ample 
evidence that the INS plays a modulatory role in drug craving and relapse in complex and 
multidimensional manner(s).  Since the INS is composed of three anatomically and 
functionally distinct subregions, each containing different neurocircuitry for mediating its 
respective functions, we reason that the disparate findings in the human literature indicate 
multiple roles for the INS in craving and relapse.  Therefore, it is likely that the role of the 
INS in craving and relapse depends upon the functional subdivision and/or circuit that were 
not observable in prior studies with standard imaging techniques. 
Figure 2: Insula damage disrupts cigarette smoking 
 
Bar graph of the seminal study investigating INS damage and cigarette smoking.  Damage 
to brain regions other than the INS resulted in a disruption of cigarette smoking in 4/50 
individuals (blue).  Damage to the INS resulted in a disruption of cigarette smoking in 
12/19 individuals (orange).  This finding has been replicated in several studies.  Adapted 
with permission from Naqvi et al. Science 315 (2007) 531-534. 
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Table 1: Studies investigating brain activity during exposure to drug cues 
 
 
 
 
The table above are a meta-analysis of functional imaging studies correlating brain activity 
and subjective drug urges.  In nearly all of the studies, individuals are exposed to drug-
associated stimuli and asked to rate their subjective urges while brain activity is measured 
via PET or FMRI scan.  Adapted with permission from Naqvi and Bechara, Brain Structure 
Function 214 (2010) 435-450. 
 
INSULAR CORTEX AND ADDICTION: RODENT STUDIES 
The INS is relatively unexplored in comparison to other mesocorticolimbic brain 
regions, but has been shown to mediate the motivational properties of drugs of abuse.  A 
comprehensive listing of all studies of our knowledge investigating the INS and addiction-
relevant behavior in rodents is presented in Table 2 (adapted from Naqvi et al., 2014).  
Since some studies did not focus specifically on the 3 anatomical and functional 
subdivisions of the INS, the subdivisions were collapsed into anterior and posterior for 
simplicity.  Anterior contains more of the AIC-DIC subdivisions and posterior contains 
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DIC-GIC, respectively. As indicated below, the majority of studies used INS inactivation 
techniques during conditioned place preference or aversion paradigms or self-
administration studies to determine whether the INS mediates motivational properties of 
drugs of abuse.  Conditioned place preference for amphetamine, morphine, and nicotine 
are sensitive to INS inactivation, suggesting INS activity mediates some of the rewarding 
aspects of these drugs (Contreras et al., 2007; Scott and Hiroi, 2011; Contreras et al., 2012; 
Li et al., 2013).  Moreover, conditioned place aversion for nicotine and morphine are also 
sensitive to INS inactivation, suggesting INS activity mediates some of the aversive aspects 
of nicotine and morphine (Scott and Hiroi, 2011; Li et al., 2013)   Drug self-administration 
studies have shown that INS activity mediates seeking behavior for drugs of abuse (Di 
Pietro et al., 2008; Hollander et al., 2008; Forget et al., 2010; Kutlu et al., 2013; Pushparaj 
et al., 2013; Pushparaj et al., 2015).  Taken together, these investigations suggest that the 
INS may mediate the recall of both rewarding and aversive aspects of past drug use, and 
may play a role in motivation to approach or avoid drugs of abuse. 
 
INSULAR CORTEX AND ADDICTION: RODENT STUDIES: ALCOHOL 
Whether the INS mediates the motivational properties of ethanol has not yet been 
sufficiently determined.  Table 2 highlights the sole 6 studies (in shading) investigating the 
INS and addiction-relevant ethanol behaviors (Seif et al., 2013; Pushparaj et al., 2015; 
Jaramillo et al., 2016; Jaramillo et al., 2017; Jaramillo et al., 2018; Lasek et al., 2017).  
Pushparaj and colleagues found that operant ethanol self-administration in rats was reduced 
by inactivation of the GIC subregion, suggesting that this subregion of the INS mediates 
initial, positively reinforced aspects of ethanol use (Pushparaj et al., 2015).  The following 
5 studies suggest that the more anterior AIC subregion mediates the interoceptive, 
discriminative stimulus effects of ethanol as well as positively and negatively reinforced 
motivational aspects of ethanol consumption.  Seif and colleagues elegantly modeled 
compulsive drug self-administration by teaching rats to self-administer ethanol despite it 
being adulterated with the bitter tastant quinine or paired with a foot shock.  Optogenetic 
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inactivation of glutamatergic terminals from the AIC to the NAc core reduced self-
administration resistant to quinine adulteration and to a foot shock.  Notably, they found 
that self-administration without adulteration with quinine or paired with a foot shock was 
unchanged by inactivation of these terminals (Seif et al., 2013).  This finding suggests a 
role for AIC circuitry mediating compulsive aspects of alcohol use characteristic of AUD.  
Jaramillo et al. (2016) found that temporary pharmacological inactivation of the AIC 
reduced the discriminative stimulus/interoceptive effects of ethanol.  Since the 
discriminative stimulus/interoceptive cues of a drug are thought to be predictive of drug-
related behaviors and potentially abuse potential, this finding suggests AIC functioning is 
linked to alcohol abuse (Koob and Volkow, 2010; Solinas et al., 2006).  A follow-up 
investigation found that temporary inhibition of the AIC and AIC inputs to the NAc core 
via Designer receptors exclusively activated by Designer Drugs (DREADDS) both 
enhanced the sensitivity to the interoceptive effects of ethanol in subsequent operant and 
pavlovian procedures (Jaramillo et al., 2017).  Although these effects are in opposition to 
earlier findings, they nonetheless add evidence that AIC activity and its output may alter 
the interoceptive effects of ethanol.  Finally, Jaramillo and colleagues found the first 
evidence that AIC and its output are involved in ethanol reinforcement.  Temporary 
inhibition of the AIC via DREADDS increased ethanol self-administration, and temporary 
inhibition of the AIC inputs to the NAc core via DREADDS decreased self-administration 
(Jaramillo et al., 2018).   Finally, Lasek and colleagues have recent evidence suggesting 
the AIC is directly recruited in animal models of advanced drinking.  Perineuronal nets 
(PNN), extracellular matrix structures that play roles in synaptic stabilization and plasticity, 
are increased in the AIC after binge ethanol exposure (Chen et al., 2015).  Digesting the 
PNN with chondroitinase ABC in the AIC reduced ethanol consumption in a model of 
binge drinking.  Importantly, the reduction in ethanol consumption was greatest for quinine 
adulterated ethanol (Lasek at al., 2017).  These data indicate that binge ethanol exposure 
increases AIC PNN expression, which then mediates both binge drinking and aversion 
resistant drinking.  Taken together, the 6 aforementioned studies investigating the INS and 
addiction-relevant ethanol behaviors suggest that the INS plays roles in both initial ethanol 
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drinking and more pathological forms of ethanol drinking depending upon the subregion 
and/or circuit of investigation.  
Table 2: Rodent studies of the insula in addiction-relevant behavior 
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The table above lists all of the rodent studies investigating the INS and addiction.  Each 
study is broken down by investigated drug of abuse, INS subregion, species (rat or mouse), 
and INS manipulation method.  The investigations of alcohol (6) are highlighted in gray.  
Adapted from Naqvi et al. Ann N Y Acad Sci 1316 (2014) 53-70. 
SYNAPTIC PLASTICITY 
Synaptic plasticity mechanisms are the means by which neural networks adapt to 
strengthen or weaken their connections to form the basis of information storage and are 
thought of as mechanisms of learning and memory (Kauer and Malenka, 2007; Kandel et 
al., 2014).  Maladaptive drug-induced forms of synaptic plasticity are accepted to 
contribute to addictive behaviors (Luscher and Malenka, 2011).  Extensive work from our 
laboratory has used the Becker-Lopez CIE-2BC model to investigate glutamatergic 
synaptic plasticity mechanisms in the nucleus accumbens encoding aspects of AUD such 
as escalated drinking (Jeanes et al., 2011; Jeanes et al., 2014; Renteria et al., 2017; Renteria 
et al., 2018).  Specifically, our laboratory has observed a form of NMDAR-dependent long-
term depression (LTD) in the nucleus accumbens shell that is disrupted over the time 
course of CIE-induced escalated drinking.  These data suggest that disrupted accumbal 
LTD contribute, in part, to the expression of ethanol dependence (Jeanes et al., 2011; 
Renteria et al., 2018).  
THE AIC AND SYNAPTIC PLASTICITY  
Of the subregions of the INS, the chemoarchitecture, circuitry, and function of the 
anterior most region, the AIC, makes it of high relevance for addiction researchers (Craig 
2002; Craig 2009).  The AIC contains high levels of D1 receptors as well as µ-opioid 
receptors, canonically associated with initial positive drug motivation and reward (Hurd et 
al., 2001; Baumgärtner et al., 2006).  Moreover, the AIC also contains high expression of 
CRF1 receptors, implicated negative drug reinforcement (Van Pett et al., 2000).  Also, 
there are prominent reciprocal connections to mesolimbic regions heavily implicated in 
motivated behavior and addiction such as the nucleus accumbens, the central amygdala, 
the locus coeruleus, and the rostromedial tegmental nucleus (Chikama et al., 1997; Kapp 
et al., 1985; Lavezzi and Zahm, 2011; Uematsu et al., 2015). We wished to determine 
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whether the actions of ethanol on the glutamate system in the AIC disrupts homeostatic 
interoceptive mechanisms and promotes aspects of AUD.  Therefore, the major focus of 
the investigation is to determine 1) Whether ethanol is a direct synaptic target for the 
actions of acute ethanol, 2) Whether functioning of the INS is disrupted by chronic ethanol 
exposure. 
Our NMDAR-dependent LTD design was based off of the Artola-Brocher-Singer 
rule of canonical NMDAR-dependent synaptic plasticity.  This rule states that the polarity 
of synaptic plasticity depends upon ability of the postsynaptic membrane to reach 
sequential thresholds and regulate postsynaptic calcium levels (Artola & Singer, 1993; Cho 
et al., 2001).  In this framework, postsynaptic calcium levels determine expression of 
plasticity; low concentrations of postsynaptic calcium cause LTD, medium postsynaptic 
calcium causes no change in synaptic strength, and that higher postsynaptic calcium levels 
cause a long-term potentiation (LTP) (Figure 3; Figure 4; Cho 2001). It has been shown in 
several investigations that chronic ethanol and withdrawal enhances NMDAR functioning 
(Roberto and Varodayan, 2017).  Therefore, since our two groups of animals, Drinking + 
CIE and Drinking + Air, will undergo significantly differential ethanol exposure, we 
predicted that they will display differential expression of synaptic plasticity.  Taken 
together we predicted that disruptions in AIC NMDAR-dependent plasticity indicate the 
transition from low-risk drinking to AUD-like drinking. 
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Figure 3: Schematic of the expression of synaptic plasticity 
 
 
 
The figure above represents how NMDAR-dependent synaptic plasticity is generated in a 
slice electrophysiology experimental preparation.  Electrophysiologists stimulate the 
postsynaptic neuron (stimulation protocol) at a certain frequency with a stimulating 
electrode to mimic in vivo presynaptic glutamatergic input.  The membrane potential of the 
postsynaptic neuron is typically slightly depolarized from the resting membrane potential 
to remove the voltage-dependent magnesium blockade of NMDARs.  Higher presynaptic 
stimulation frequencies typically result in the insertion of AMPARs or enhanced 
presynaptic glutamate release, causing the expression of long term potentiation (LTP).  
Lower stimulation frequencies typically result in the removal of AMPARs or reduced 
presynaptic glutamate release, causing the expression of long term depression (LTD).     
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Figure 4: Schematic of NMDAR-dependent synaptic plasticity and our hypothesis 
 
 
 
The figure above represents the canonical mechanism for NMDAR-dependent synaptic 
plasticity (left) and our experimental prediction (right).  The polarity of NMDAR-
dependent synaptic plasticity is dependent upon postsynaptic calcium influx.  Higher 
presynaptic stimulation frequencies typically cause a large NMDAR activation, leading to 
large amounts of postsynaptic calcium influx and the activation of proteins causing LTP.  
Lower presynaptic stimulation frequencies typically cause a lower NMDAR activation, 
leading to smaller amounts of postsynaptic calcium influx and the activation of proteins 
causing LTD.  From this model, and the fact that chronic ethanol has shown to enhance 
NMDAR activation levels, we predicted a difference in the expression of plasticity between 
Drinking + Air and Drinking + CIE groups.  Since Drinking + CIE mice experience more 
chronic ethanol action and withdrawal, we predicted a more LTP-like phenotype in 
Drinking + CIE relative to Drinking + Air mice.  
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Chapter 2:   
Ethanol Modulates Glutamatergic Transmission and NMDAR-Mediated Synaptic 
Plasticity in the Agranular Insular Cortex  
This chapter has been accepted for publication in Frontiers in Pharmacology  
Authors: Joel Shillinglaw, Richard Morrisett, Regina Mangieri. Joel Shillinglaw and 
Richard Morrisett conceived and designed experiments.  Joel Shillinglaw performed the 
experiments.  Joel Shillinglaw and Regina Mangieri analyzed the data and interpreted the 
results.   Joel Shillinglaw and Regina Mangieri wrote the paper.    
 
ABSTRACT   
  The agranular insular cortex (AIC) has recently been investigated by the alcohol 
field because of its connectivity to and modulatory control over limbic and brainstem 
regions implicated in alcohol use disorder (AUD), and because it has shown involvement 
in animal models of alcohol drinking.  Despite evidence of AIC involvement in AUD, 
there has not yet been an examination of whether ethanol modulates glutamatergic and γ-
amino-butyric acid (GABA)ergic synaptic transmission and plasticity in the AIC.  
Characterizing how the synaptic transmission and plasticity states of AIC cortical 
processing neurons are modulated by acute ethanol will likely reveal the molecular targets 
by which chronic ethanol alters AIC function as alcohol drinking transitions from 
controlled to problematic.  Therefore, we collected brain slices from ethanol-naïve adult 
male mice, obtained whole-cell recording configuration in layer 2/3 AIC pyramidal 
neurons, and bath-applied ethanol at pharmacologically relevant concentrations during 
electrophysiological assays of glutamatergic and GABAergic synaptic transmission and 
plasticity.  We found that ethanol inhibited electrically evoked N-methyl-D-aspartate 
receptor (NMDAR)-mediated excitatory postsynaptic currents (EPSCs) in a 
concentration-related fashion, and had little effect on evoked α-amino-3-hydrox-5-
methylisoxazole-4-propionic acid-type receptor (AMPAR)-mediated EPSCs.  Ethanol 
had no effect on spontaneous excitatory postsynaptic currents (sEPSCs) or inhibitory 
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GABAAR-mediated postsynaptic currents (sIPSCs).  We found that synaptic conditioning 
(low-frequency stimulation for 15 min at 1 Hz) induced a form of long-term depression 
(LTD) of evoked AMPAR-mediated EPSCs.  The ability to induce LTD was inhibited by 
a nonselective NMDAR antagonist (DL-2-amino-5-phosphonovaleric acid), and also by 
acute, intoxicating concentrations of ethanol.  Taken together these data suggest that the 
glutamate, but not GABA system in the AIC is uniquely sensitive to ethanol, and that in 
particular NMDAR-mediated processes in the AIC may be disrupted by 
pharmacologically relevant concentrations of ethanol. 
 
INTRODUCTION   
Despite several years of preclinical research investigating the mechanisms 
underlying the transition from controlled to problematic alcohol drinking in order to 
develop future therapeutic approaches, alcohol use disorder (AUD) remains one of the 
most prevalent and costly health problems in the United States (Sacks et al., 2015; Stahre 
et al., 2014).  Current pharmacological and behavioral treatments have achieved only 
moderate success largely due to their inability to decrease the vulnerability to relapse in 
abstinent addicts (Scofield et al., 2016).  Therefore, investigating the neural networks 
implicated in the craving and relapse components of AUD is vital to developing more 
efficacious treatment options.  Recent research suggests that deficits in interoceptive 
processing, or the processing and integration of physiological bodily states, may in part 
contribute to craving and relapse components of substance use disorders (Paulus and 
Stewart, 2014). 
The agranular insular cortex (AIC) is a brain region implicated in interoceptive 
processing, and altered AIC function and output to subcortical limbic regions has been 
shown to mediate alcohol intake in animal models of AUD (Seif et al., 2013; Jaramillo et 
al., 2016; Jaramillo et al., 2017; Jaramillo et al., 2018).  Yet despite evidence for altered 
AIC function and output in AUD, there has been no investigation of whether the AIC is 
an ethanol-sensitive brain region in which basic synaptic functions are modulated by 
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pharmacologically relevant concentrations of acute ethanol.  It is widely accepted that the 
synapse is sensitive to ethanol, and that ethanol’s major pharmacodynamic effects occur 
at least in part via its modulatory actions on the major fast excitatory and inhibitory 
neurotransmitter systems, glutamate and gamma-aminobutyric acid (GABA), 
respectively.  However, these synaptic actions have been shown to be both brain region 
and concentration-dependent (Nie et al., 1994; Lovinger et al., 1990; Roberto et al, 2003; 
Weitlauf et al., 2008; Badanich et al., 2013; Kash et al., 2008).   
Moreover, the synaptic targets of acute ethanol have generally displayed opposing 
or compensatory effects after chronic ethanol exposure in animal models designed to 
mimic long-term alcohol abuse (Lovinger and Roberto, 2013).  These compensatory 
effects of chronic ethanol on synaptic receptors have been shown to encode long-term 
alterations in glutamatergic and GABAergic transmission and to underlie, in part, aspects 
of AUD such as withdrawal, tolerance and dependence (Jeanes et al., 2011; Renteria et 
al., 2017; Lovinger & Kash., 2015; Lovinger and Roberto, 2013).  We therefore suggest 
that any synaptic target in the AIC that is sensitive to acute ethanol may be a target by 
which chronic ethanol disrupts AIC function as chronic ethanol shifts alcohol drinking 
from controlled to problematic. 
For these reasons we investigated the effects of acute ethanol on 
pharmacologically isolated glutamatergic and GABAergic synaptic transmission, and an 
N-methyl D-aspartate-type glutamate receptor (NMDAR)-dependent glutamatergic 
synaptic plasticity in mouse AIC.  We decided to investigate layer 2/3 pyramidal neurons 
since layer 2/3 of the cortex is generally considered the intracortical processing layer.  
We found that NMDAR-mediated currents were inhibited by pharmacologically relevant 
concentrations of ethanol.  Conversely, alpha-amino-3-hydroxy-5-methylisoxazole-4- 
propionic acid-type glutamate receptor (AMPAR)-mediated currents were insensitive to 
ethanol.  Ethanol had no effect on spontaneous excitatory postsynaptic currents (sEPSCs) 
or spontaneous inhibitory γ-amino-butyric acid receptor (GABAR)-mediated 
postsynaptic currents (sIPSCs).  Our investigated form of synaptic plasticity, NMDAR-
dependent long-term depression (LTD), was sensitive to pharmacologically relevant 
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concentrations of ethanol.   These findings are the initial demonstration that the AIC is a 
direct synaptic target for the actions of ethanol, and that glutamatergic transmission and 
plasticity, but not GABAergic transmission, is sensitive to pharmacologically relevant 
concentrations of acute ethanol.   
 
METHODS  
Preparation of Brain Slices 
Mice were briefly anesthetized with isoflurane, euthanized by decapitation, and 
then brains were rapidly extracted and placed in ice-cold oxygenated artificial 
cerebrospinal fluid (ACSF) containing the following (in mM): 210 Sucrose, 26.2 
NaHCO3, 1 NaH2PO4, 2.5 KCl, 11 dextrose, bubbled with 95% O2/5% CO2.  Coronal 
slices (230 to 250 µm thick) containing the most anterior portion of the AIC (anterior-
posterior = +2.46 to +1.54) were then collected in ice-cold oxygenated ACSF using a 
Leica VT1000S vibrating microtome (Leica Corp., Bannockburn, IL).  Slices were then 
transferred into an incubation solution containing the following (in mM): 120 NaCl, 25 
NaHCO3, 1.23 NaH2PO4, 3.3 KCl, 2.4 MgCl2, 1.8 CaCl2, 10 dextrose, continuously 
bubbled with 95% O2/ 5% CO2; 32°C, and maintained in this solution at least 45 min 
prior to recording. 
 
Patch-Clamp Electrophysiology 
Whole cell voltage clamp recordings were made in layer 2/3 pyramidal AIC 
neurons from anterior-posterior = +2.46 to +1.54.  Pyramidal neurons were identified 
based on morphology (large, pyramidal shape) using a MRK200 Modular Imaging 
system (Siskiyou Corporation, Grants Pass, OR) mounted on a vibration isolation table. 
Passive electrical membrane properties for each cell at the beginning and end of each 
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experiment are provided in Tables 1-7.  Recordings were made in ACSF containing (in 
mM): 120 NaCl, 25 NaHCO3, 1.23 NaH2PO4, 3.3 KCl, 1.2 MgSO4, 2.0 CaCl2, and 10 
dextrose unless otherwise noted, bubbled with 95% O2/ 5% CO2; 32°C, controlled by an 
in-line bath heather (Warner Instruments, Hamden, CT).  The bath ACSF perfused brain 
slices at a rate of 2.0 mL/min.  Recording electrodes (thin-wall glass, WPI Instruments, 
Sarasota FL) were made using a P-97 Flaming/Brown model micropipette puller (Sutter 
Instruments, San Rafael, CA) which produced electrodes of resistances from 3-6 MΩ.  
Series resistance (Rs) was monitored throughout the duration of each experiment and 
cells with Rs of over 30 MΩ or that changed over 20% over the course of the experiment 
were excluded from the analysis. 
All chemicals, unless otherwise noted, were obtained from Sigma-Alrich or 
Tocris Bioscience with the exception of ethanol, which was obtained from Pharmco-
Aaper.  Multiple cells per brain slice were sometimes recorded from in glutamatergic and 
GABAergic transmission experiments, but only when the first cell recorded from was 
assigned to the time and sham solution exchange control condition.  Thus, the final 
recording for each brain slice occurred once the slice was exposed to ethanol.  For LTD 
experiments, only one cell per brain slice was used. 
 
Evoked Glutamatergic Transmission 
For evoked excitatory (NMDAR-mediated) postsynaptic currents, recording 
electrodes were filled with (in mM): 120 CsMeSO4, 15 CsCl, 8 NaCl, 10 HEPES, 0.2 
EGTA, 10 TEA-Cl, 4 Mg-ATP, 0.3 Na-GTP, 0.1 Spermine, and 5 QX-314-Cl.  DNQX 
(20 µM) was added to the recording ACSF to block AMPA receptors, along with 
picrotoxin (50 µM) to block GABAA receptors.  The recording ACSF for evoked 
NMDAR-mediated experiments contained 1.0 mM MgSO4, and EPSCs were evoked by 
local stimulation while holding the postsynaptic membrane voltage at -40 mV for 2.4 
seconds.  For evoked excitatory (AMPAR-mediated) postsynaptic currents, recording 
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electrodes were filled with (in mM): 120 K-gluconate, 10 KCl, 10 HEPES, 2 MgCl2, 1 
EGTA, 2 Mg-ATP, and 0.3 Tris-GTP.  DL-APV (100 µM) was added to the recording 
ACSF to block NMDA receptors, along with picrotoxin (50 µM).  Neurons in evoked 
AMPAR-mediated experiments were held at -70 mV for the entirety of the experiment. 
For both evoked AMPAR-mediated and NMDAR-mediated postsynaptic current 
experiments, standard evoked EPSCs were established for at least 8 min (at 0.025 Hz) to 
ensure stable recordings, followed by 10 min periods of ethanol treatment and ethanol 
washout.  Additional validation experiments were conducted to confirm that the currents 
under investigation were mediated by the receptors of interest.  Evoked NMDA-mediated 
synaptic currents were reduced in amplitude by ≈ 78% by 100 µM DL-APV, and evoked 
AMPAR-mediated synaptic currents were reduced in amplitude by ≈ 93% by 20 µM 
DNQX (data not shown). 
Spontaneous Glutamatergic and GABAergic Transmission  
For spontaneous excitatory postsynaptic currents (sEPSCs), recording electrodes 
were filled with (in mM): 135 KMeSO4, 12 NaCl, 0.5 EGTA, 10 HEPES, 2 Mg-ATP, 
and 0.3 Tris-GTP.  Picrotoxin (50 µM) was added to the recording ACSF.  For 
spontaneous inhibitory postsynaptic currents (sIPSCs), recording electrodes were filled 
with (in mM): 120 CsCl, 10 HEPES, 2 MgCl2, 1 EGTA, 2 Mg-ATP, 0.3 Tris-GTP, and 
1 QX-314.  Kynurenic acid (1 mM) was added to the recording ACSF to block AMPA 
and NMDA receptors.   For both spontaneous excitatory and inhibitory postsynaptic 
current experiments, neurons were held at -70 mV for 10 min to ensure stable recordings, 
followed by 10 min periods of ethanol treatment and ethanol washout.  Additional 
validation experiments were conducted to confirm that the currents under investigation 
were mediated by the receptors of interest.  sEPSCs were reduced in frequency by ≈ 93% 
by 1 mM kynurenic acid, and sIPSCs were reduced in frequency by ≈ 95% by 50 µM 
picrotoxin (data not shown). 
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Synaptic Plasticity 
For LTD synaptic plasticity experiments, recording electrodes were filled with 
(in mM): 120 K-gluconate, 10 KCl, 10 HEPES, 2 MgCl2, 1 EGTA, 2 Mg-ATP, and 0.3 
Tris-GTP.  Neurons were held at -70 mV for the entirety of the experiment, and the ACSF 
was supplemented with picrotoxin (50 µM).  Standard evoked EPSCs were established 
for at least 10 min (at 0.025 Hz) to ensure stable recordings, and then followed by a low-
frequency stimulation protocol consisting of 1 Hz stimulation for 15 min.  Evoked EPSCs 
were then monitored for a 30 min post-stimulation period at 0.025 Hz to test for the 
expression of LTD. 
Data Acquisition & Analysis  
All currents were acquired using an Axopatch 200B amplifier (Axon Instruments, 
Foster City, CA), filtered at 1 kHz, and digitized at 10-20 kHz via a Digidata 1440A 
interface board using pClamp 10.2 (Axon Instruments).  In spontaneous experiments, 
sEPSCs and sIPSCs were recorded for 30 min and separated into 198 consecutive sweeps; 
events greater than 5 pA and 10 pA were analyzed in sEPSC and sIPSC experiments, 
respectively, for mean frequency and mean amplitude.  For all evoked experiments, 
postsynaptic currents (100-200 pA) were evoked via either theta glass electrode or a 
stainless steel bipolar stimulating electrode (MX21AES, FHC, Inc., Bowdoin, ME, 
United States) placed approximately 500 µm dorsomedial to the cell body (Figure 1). 
For all experiments investigating acute ethanol on GABAergic and glutamatergic 
transmission, we used two approaches to statistical analysis.  First, a General Linear 
Model Repeated Measures in IBM SPSS Advanced Statistics 23 was used, with time or 
phase of the experiment as the repeated measure, and treatment condition (ethanol 
concentration) as the between-groups factor.  For evoked currents, we analyzed the entire 
time course of the experiment, with 28 levels of the repeated measure (time), and 4 levels 
(eNMDAR) or 5 levels (eAMPAR) of the between-groups factor (treatment condition).  
For spontaneous currents, we used phase of the experiment as the repeated measure (3 
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levels: baseline, treatment, and washout) and treatment condition as the between-groups 
factor (2 levels).  When sphericity within groups was violated (as indicated by Mauchly’s 
test), the Greenhouse-Geisser adjusted degrees of freedom and p values were reported in 
the text, rounded to the nearest whole number.  Second, we also analyzed the effects of 
ethanol on evoked and spontaneous currents without the use of a repeated measure. We 
used a 1-way between groups ANOVA to compare treatment conditions during a 
particular phase of the experiment – either the treatment phase (for evoked NMDAR) or 
the washout phase (for evoked AMPAR).  These were followed by Bonferroni-corrected 
multiple comparisons.  For spontaneous currents, we performed between groups analysis 
(t-test) to compare treatment conditions during just the treatment phase.  GraphPad Prism 
8.0 was used to analyze LTD experiments.  The expression of LTD was determined by 
comparing the 20 to 30 min period after the low-frequency stimulation protocol to the 10 
min baseline period.  Statistical significance from baseline for within each treatment 
group was defined as p < 0.05 using a one-sample t test.  Group comparisons for LTD 
experiments were made using a one-way ANOVA and Bonferroni post hoc test.  
Statistical significance for all experiments was defined as p < 0.05.   
Mice 
Ethanol-naïve Drd1a-tdTomato BAC transgenic male mice (MMRRC:030512-
UNC) of at least 7 weeks of age were used for all experiments.  Briefly, an existing colony 
of Drd1a-tdTomato mice (Ade et al., 2011; initial breeding pairs obtained from The 
Jackson Laboratory, Stock No. 016204) was maintained by backcrossing mice onto a 
C57BL/6J background in which only one parent carried the Drd1a-tdTomato transgene 
(as described in Mangieri et al., 2017).  Mice were group-housed (up to five mice per 
cage) in standard cages (7.5” x 11.5” x 5”) with Sani-Chips wood bedding (PJ Murphy) 
at 22°C with a 12:12 light: dark cycle (lights off at 9:30AM).  Water and standard chow 
(LabDiet®5LL2 Prolab RMH1800) were available ad libitum, and all experimental 
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procedures were approved by the University of Texas Institutional Animal Care and Use 
Committee. 
 
RESULTS  
Ethanol-sensitivity of evoked NMDAR-type glutamatergic transmission  
NMDAR-mediated currents were evoked for 8 min to ensure steady baseline 
responses before slices were perfused with an ethanol-containing ACSF for a 10 min 
treatment period, followed by a 10 min ethanol washout period (Figure 2).  When 
analyzed over the entire 28 min experiment, we observed that the effect of time on 
NMDAR-mediated EPSC amplitude was not uniform, but varied with the treatment 
condition (two-way repeated measures ANOVA, main effect of time: F(3,86) = 4.7, p = 
0.004; time x treatment interaction: F(12,86) = 2.3, p = 0.013), indicating that the changes 
in EPSC amplitude over the course of the experiment were not due to time alone. This 
conclusion was further supported by a significant between-groups effect during the 
treatment period (F(4,29) = 8.1, p < 0.001), when higher concentrations of ethanol (≥ 40 
mM) all displayed significant reduction of peak NMDAR-mediated response relative to 
control (Figure 2C).  
Ethanol-sensitivity of evoked AMPAR-type glutamatergic transmission 
Ethanol has been shown to inhibit NMDAR-mediated currents across several 
brain regions, but has also been shown to inhibit AMPAR-mediated currents (Lovinger 
and Roberto, 2013).  In order to test the sensitivity of AMPAR-mediated currents to 
ethanol, we tested whether ethanol modulated evoked AMPAR-mediated transmission.  
Therefore, neurons were voltage-clamped at -70 mV, and EPSCs were evoked in the 
presence of 100 µM DL-APV and 50 µM picrotoxin to isolate AMPAR-mediated 
currents.  Following 8 min of recording to ensure steady baseline responses, neurons were 
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perfused with an ethanol-containing ACSF for a 10 min treatment period, followed by a 
10 min ethanol washout period. 
We observed no effect of time or time x treatment condition interaction on 
AMPAR-mediated EPSC amplitude over the entire 28 minute experiment (Figure 3; two-
way repeated measures ANOVA, main effect of time: F(2,37) = 1.9, n/s; time x treatment 
interaction: F(6,37) = 1.7, n/s).  In the 60 mM and 80 mM treatment concentrations, there 
appeared to be a delayed enhancement of peak AMPAR-mediated EPSCs during the last 
2 min of the 10 min washout period (Figure 3C).  However, one-way ANOVA comparing 
treatment conditions during this time period indicated these enhancements were not 
statistically significant (F(3,20) = 1.44, n/s).  
Ethanol-sensitivity of sEPSCs 
As a final assay of whether ethanol modulates glutamatergic transmission onto 
layer 2/3 AIC pyramidal neurons, we tested whether acute ethanol modulates 
spontaneous EPSCs (sEPSCs) in the AIC.  Ethanol has been shown to reduce presynaptic 
glutamate release in multiple brain regions (Lovinger and Roberto, 2013).  We assumed 
that any ethanol-induced changes in sEPSC frequency would be indicative of changes in 
presynaptic glutamate release, while ethanol-induced changes in sEPSC mean amplitude 
would be indicative of changes in postsynaptic sensitivity to glutamate (Siggins et al., 
2005).  Therefore, neurons were voltage-clamped at -70 mV, and sEPSCs were recorded 
in the presence of 50 µM picrotoxin to yield glutamate receptor-mediated spontaneous 
currents.  Following 10 min of recording to ensure steady baseline responses, neurons 
were perfused with an ethanol-containing ACSF for a 10 min treatment period, followed 
by a 10 min ethanol washout period. 
For the effect of ethanol on mean frequency of sEPSCs, we observed that an effect 
of time on sEPSC frequency did not vary by treatment condition (Figure 4; two-way 
repeated measures ANOVA, main effect of time: F(2,30) = 4.2, p = 0.025; time x 
treatment interaction: F(2,30) = 1.41, n/s).  We also directly compared the two treatment 
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conditions (control vs. 50 mM ethanol) during just the treatment phase of the experiment, 
but this analysis also did not indicate a statistically significant effect of ethanol: t(15) = 
1.756, n/s. Thus, although sEPSC frequency appeared to decrease with the application of 
50 mM ethanol, the magnitude of this change was not different than that observed in the 
control treatment group.  For the effect of ethanol on mean amplitude of sEPSCs, we 
observed no effect of time or interaction of time with treatment condition (Figure 4; two-
way repeated measures ANOVA, main effect of time: F(2,30) = 2.3, n/s; time x treatment 
interaction: F(2,30) = 0.84, n/s), nor a difference in treatment conditions during the 
treatment period: t(15) = 1.607, n/s.  
Ethanol-sensitivity of sIPSCs 
In addition to our investigation of the effects of acute ethanol on glutamatergic 
transmission, we wished to characterize whether ethanol modulates GABAergic 
transmission in the AIC.  Acute ethanol has been shown to modulate GABAergic 
transmission in several brain regions and experimental preparations (Lovinger and 
Roberto, 2013).  Therefore, we tested whether acute ethanol modulated GABAAR-
mediated spontaneous IPSCs (sIPSCs) in the AIC.  Neurons were voltage-clamped at -70 
mV, and sIPSCs were recorded in the presence of 1 mM kynurenic acid to block 
glutamatergic transmission.  Following 10 min of recording to ensure steady baseline 
responses, neurons were perfused with an ethanol-containing ACSF for a 10 min 
treatment period, followed by a 10 min ethanol washout period. 
For the effect of ethanol on mean frequency of sIPSCs, we observed no effect of 
time on mean frequency of sIPSCs and no time x treatment condition interaction (Figure 
5; two-way repeated measures ANOVA, main effect of time: F(1,18) = 1.52, n/s; time x 
treatment interaction: F(1,18) = 0.24, n/s).  We also found no difference between 
treatment conditions (control vs. 50 mM ethanol) during the treatment phase: t(15) = 
0.031, n/s.  For the effect of ethanol on mean amplitude of sIPSCs, we observed no effect 
of time on mean amplitude of sIPSCs and no time x treatment condition interaction 
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(Figure 5; two-way repeated measures ANOVA, main effect of time: F(2,30) = 0.43, n/s; 
time x treatment interaction: F(2,30) = 1.79, n/s).  A separate comparison of just the 
treatment phase of the experiment also did not reveal a statistically significant difference 
between control and 50 mM ethanol: t(15)=1.058, n/s. 
LTD in AIC layer 2/3 in ethanol-naïve mice 
We found that in the presence of 50 µM picrotoxin, local low frequency 
stimulation (1 Hz for 15 min) induced long-term depression (LTD) of evoked EPSCs in 
layer 2/3 AIC pyramidal neurons (Figure 6A, B; one-sample t-test, t = 4.622, p = 0.0007).  
To investigate whether the reduction in EPSC magnitude observed was due to either 
presynaptic changes in glutamatergic release or postsynaptic changes in glutamate 
receptor sensitivity, we measured paired-pulse ratios (2 pulses, 50 ms apart) before the 
10 min of baseline recording and after the 30 min of post-stimulation in a separate group 
of neurons.  Neurons tested for paired-pulse ratios displayed equivalent post-conditioning 
EPSC amplitudes to that seen in naïve control neurons (Figure 6B; unpaired t-test, t = 
0.05, n/s).   We observed no change in paired-pulse ratios before and after the induction 
of LTD, indicating that LTD in layer 2/3 AIC neurons is not due to changes in presynaptic 
glutamate release (Figure 6C, D; paired t-test, t = 2.484, n/s).  
LTD in AIC layer 2/3 in ethanol-naïve mice is NMDAR-dependent and ethanol-
sensitive 
An investigation from Liu and colleagues was the initial demonstration and 
investigation of LTD in the mouse INS (Liu et al., 2013).  They found via field potential 
recordings that low frequency stimulation in adult mouse INS can induce LTD of evoked 
excitatory postsynaptic potentials that depends upon NMDAR activation.  Since this is 
the first investigation of whole cell LTD in the INS, we wished to determine whether our 
observed form of LTD similarly depended upon NMDAR activation.  Bath application 
of the nonselective NMDA receptor antagonist DL-APV (100 µM) blocked the 
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expression of LTD (Figure 7; one-sample t-test, t = 0.154, n/s).  Acute ethanol has been 
shown to modulate the expression NMDAR-dependent forms of synaptic plasticity in 
multiple brain regions (McCool, 2011).  Therefore, we next tested whether acute 
pharmacologically relevant concentrations of ethanol modulate the expression of layer 
2/3 AIC pyramidal neuron LTD.  Bath application of multiple concentrations of ethanol 
(20, 40, 60 mM) did not differ in their ability to block the expression of AIC LTD (Figure 
8; one-way ANOVA, F(2,17) = 0.16, n/s).  
 
Figure 5: Representative diagram of recording site and bipolar stimulating electrode 
placement 
 
 
  
Figure 5.  Representative diagram of recording site and bipolar stimulating electrode 
placement.  The boundaries of the area from which neurons were selected for recordings 
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are inside the black box.  The boundaries of the stimulating electrode are located ≈ 500 
µm dorsomedial to the recording electrode.  aca = anterior commissure, AIC = agranular 
insular cortex, fmi = forceps minor of the corpus callosum, pir = piriform cortex, rf = 
rhinal fissure. 
 
Figure 6: Ethanol inhibits evoked NMDAR-mediated EPSCs in AIC layer 2/3 
pyramidal neurons 
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Figure 6.  Ethanol inhibits evoked NMDAR-mediated EPSCs in AIC layer 2/3 pyramidal 
neurons.  (A) Representative traces from a single neuron showing evoked NMDAR-
mediated EPSCs before and after treatment of acute ethanol (40 mM).  (B) Normalized 
timecourse of evoked NMDAR EPSC (eNMDA) responses in either sham solution 
exchange (open circles) or 40 mM ethanol application (open triangles) conditions.  The 
white bar displays the 8 min baseline period, the gray bar displays the 10 min treatment 
period, and the dark gray bar shows the 10 min washout period.  (C) Bars show average 
eNMDA EPSC amplitudes during the last 2 min of each period of the experiment 
(Baseline, Treatment, Washout), expressed as a percentage of the entire 8 min baseline 
average.  Values are expressed as averages ± S.E.M. *, p < 0.05 compared to control 
during treatment.  **, p < 0.01 compared to control during treatment.  #, p < 0.05 
compared to 20 mM during treatment.  ##, p < 0.01 compared to 20 mM during treatment 
(Control, n = 4 neurons/4 slices/2 mice; 20 mM, n = 8 neurons/8 slices/4 mice; 40 mM, 
n = 7 neurons/7 slices/4 mice; 60 mM, n = 7 neurons/7 slices/4 mice; 80 mM, n = 8 
neurons/8 slices/4 mice).  
Figure 7: Ethanol has no effect on evoked AMPAR-mediated EPSC amplitudes in 
AIC layer 2/3 pyramidal neurons 
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Figure 7.  Ethanol has no effect on evoked AMPAR-mediated EPSC amplitudes in AIC 
layer 2/3 pyramidal neurons.  (A) Representative traces from a single neuron showing 
evoked AMPAR-mediated EPSCs before and after treatment with acute ethanol (80 
mM).  (B) Normalized timecourse of evoked AMPAR EPSC (eAMPA) responses in 
either sham solution exchange (open circles) or 80mM ethanol application (open 
triangles) conditions.  The white bar displays the 8 min baseline period, the gray bar 
displays the 10 min treatment period, and the dark gray bar shows the 10 min washout 
period.  (C) Bars show average eAMPA amplitudes during the last 2 min of each period 
of the experiment (Baseline, Treatment, and Washout), expressed as a percentage of the 
entire 8 min baseline average.  Values are expressed as averages ± S.E.M (Control, n = 
4 neurons/4 slices/3 mice; 40 mM, n = 6 neurons/6 slices/4 mice; 60 mM, n = 5 
neurons/5 slices/4 mice; 80 mM, n = 9 neurons/9 slices/7 mice). 
  
Figure 8: Ethanol has no effect on spontaneous EPSCs in AIC layer 2/3 pyramidal 
neurons 
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Figure 8. Ethanol has no effect on spontaneous EPSCs in AIC layer 2/3 pyramidal 
neurons.  (A) Representative traces from a single neuron showing spontaneous EPSCs 
(sEPSCs) before and after treatment with acute ethanol (50 mM). (B) Summary charts 
showing mean frequency (left) and amplitude (right) of sEPSCs during the last 2 min of 
each period of the experiment (Baseline, Treatment, and Washout), expressed as a 
percentage of the entire 10 min baseline average.  Values are expressed as averages ± 
S.E.M (Control, n = 8 neurons/8 slices/6 mice; 50 mM, n = 9 neurons/9 slices/7 mice). 
 
Figure 9: Ethanol has no effect on spontaneous GABA IPSCs in AIC layer 2/3 
pyramidal neurons 
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Figure 9.  Ethanol has no effect on spontaneous GABA IPSCs in AIC layer 2/3 pyramidal 
neurons.  (A) Representative traces from a single neuron showing spontaneous IPSCs 
(sIPSCs) before and after treatment with acute ethanol (50 mM). (B) Summary charts 
showing mean frequency (left) and amplitude (right) of sIPSCs during the last 2 min of 
each period of the experiment (Baseline, Treatment, and Washout), expressed as a 
percentage of the entire 10 min baseline average. Values are expressed as averages ± 
S.E.M (Control, n = 6 neurons/6 slices/6 mice; 50 mM, n = 11 neurons/11 slices/9 mice). 
 
Figure 10.  Low-frequency stimulation produces LTD at glutamatergic synapses 
onto AIC layer 2/3 pyramidal neurons 
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Figure 10.  Low-frequency stimulation produces LTD at glutamatergic synapses onto 
AIC layer 2/3 pyramidal neurons.  (A) Representative traces from a single neuron 
showing evoked EPSCs before and 20-30 min after low-frequency conditioning 
stimulation protocol (900 pulses at 1 Hz while holding the neuron at -70 mv).  (B) 
Conditioning stimulation induced long-term depression of evoked EPSCs onto AIC layer 
2/3 pyramidal neurons of ethanol-naïve mice (12 neurons/12 slices/9 mice, ***p = 0.0007 
compared to baseline).  (C) Representative traces from a single neuron showing evoked 
paired pulse ratios before baseline and after the post-conditioning period.  (D) Bar graph 
representing the mean PPR ± S.E.M. before baseline and after the post-conditioning 
period.  PPR was determined by dividing the amplitude of EPSC2 by EPSC1 for each 
sweep.  Average PPRs before baseline and after post-conditioning were not significantly 
different (n = 6 neurons/6 slices/4 mice; paired t-test, t = 2.48, n/s).  Values are expressed 
as averages ± S.E.M.  
 
 
Figure 11.  NMDA receptors are required for AIC layer 2/3 pyramidal neuron LTD 
expression 
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Figure 11.  NMDA receptors are required for AIC layer 2/3 pyramidal neuron LTD 
expression.  (A) Representative traces from a single neuron showing evoked EPSCs before 
and 20-30 min after low-frequency conditioning stimulation protocol in the presence of the 
nonselective NMDA receptor antagonist DL-APV (100 µM).  (B) Conditioning stimulation 
did not induce LTD expression in the presence of DL-APV (100 µM), (7 neurons/7 slices/6 
mice, p > 0.05 versus baseline).  Values are expressed as averages ± S.E.M. 
 
Figure 12.  In vitro ethanol exposure blocks AIC layer 2/3 pyramidal neuron LTD 
expression 
 
 
Figure 12.  In vitro ethanol exposure blocks AIC layer 2/3 pyramidal neuron LTD 
expression.  (A) Representative traces from a single neuron of each ethanol group showing 
evoked EPSCs before and 20-30 min after low-frequency conditioning stimulation protocol 
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in the presence of acute ethanol.  (B)  Conditioning stimulation did not induce LTD 
expression in the presence of acute ethanol (20, 40, or 60 mM).  (C) Bar graph representing 
the average post-conditioning (min 45-55) EPSC amplitude as percentage of baseline for 
each ethanol concentration.  Control LTD value from prior experiment (Figure 6) shown 
for comparison.  Values are expressed as averages ± S.E.M (Control LTD, n = 12 
neurons/12 slices/9 mice; 20 mM, n = 7 neurons/7 slices/5 mice; 40 mM, n = 6 neurons/6 
slices/5 mice; 60 mM, n = 7 neurons/7 slices/5 mice). 
DISCUSSION  
Ethanol has multiple effects on the glutamate system 
The major findings of this investigation are that acute ethanol has significant 
effects on glutamatergic transmission and glutamatergic synaptic plasticity in layer 2/3 
AIC pyramidal neurons, but little to no effect on GABAergic transmission at the 
concentration tested (50 mM).  Recordings from brain slice preparations across multiple 
brain regions have generally shown an inhibitory effect of acute ethanol on glutamatergic 
transmission (Lovinger and Roberto, 2013).  This effect is largely attributed to ethanol’s 
inhibitory actions on postsynaptic NMDARs (Ron and Wang, 2009). Since acute ethanol 
has been shown to modulate glutamatergic transmission across several brain regions and 
experimental preparations (Lovinger and Roberto, 2013), we wished to determine 
whether ethanol modulates glutamatergic intracortical processing in the AIC.  A 
commonly replicated synaptic effect of ethanol across multiple brain regions has been its 
inhibitory action on postsynaptic NMDARs, as ethanol has generally been found to have 
a concentration-dependent inhibition of NMDAR-mediated transmission (Ron and 
Wang, 2009).  Moreover, ethanol’s inhibitory effects on NMDARs and disruption of 
NMDAR-dependent signaling processes have been shown to be major canonical 
mechanisms by which chronic ethanol disrupts healthy brain functioning; NMDAR-
dependent synaptic mechanisms of learning and memory have generally been shown to 
be disrupted by chronic alcohol use and implicated in alcohol-related phenotypes (Ron 
and Wang, 2009).  For these reasons we tested whether ethanol inhibited postsynaptic 
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NMDARs in layer 2/3 AIC pyramidal neurons.  Our investigation determined that ethanol 
modestly inhibited evoked NMDAR-mediated currents in the AIC in a concentration-
related manner.  Such a finding complements research in other brain regions which 
identifies NMDARs as a modest (≈ 25% inhibition) ethanol-sensitive target in cortical 
neurons (Lovinger and Roberto, 2013). However, it is important to consider that no 
statistically significant inhibition of evoked NMDAR-mediated EPSCs was observed at 
20 mM, an intoxicating ethanol concentration.  Therefore, our data, at initial 
consideration, suggest that the action of ethanol on NMDARs in the AIC is a modest 
effect observable only at highly intoxicating concentrations (≥ 40 mM) of ethanol. 
However, it is possible that ethanol’s action on AIC NMDARs in vivo occurs at 
lower ethanol concentrations and at greater peak inhibition levels than what we observed 
in the current study due the limitations of a brain slice preparation.  For example, a well-
established modulator of the degree of ethanol inhibition on evoked NMDAR-mediated 
responses is the ACSF Mg2+ concentration, as studies have shown that higher Mg2+ 
concentrations increase the sensitivity of NMDARs to ethanol (Ron and Wang, 2009; 
Carlton et al., 1998).  Prior research investigating ethanol’s inhibitory effect on NMDARs 
utilizing expression systems has shown that the degree of ethanol inhibition of NMDARs 
is Mg2+-dependent (Jin et al., 2008).  Our experimental design utilized a concentration of 
Mg2+ (1.0 mM) that has been shown to produce significant inhibition of evoked NMDAR 
currents of pyramidal neurons in the basolateral amygdala (Carlton et al., 1998).  Since 
normal cerebrospinal Mg2+ concentration in healthy people is estimated to be around 1.48 
mM, due to enhanced free Mg2+ in human cerebrospinal fluid, AIC NMDARs may be 
more sensitive to the inhibitory effects of ethanol under physiological conditions than 
under those of our brain slice preparation (Banki et al., 1985). 
Nonetheless, even if the modest level of inhibition observed only at higher ethanol 
concentration levels (40, 60, 80 mM) in this study fully replicate in vivo conditions, we 
still maintain that this inhibitory effect is a significant phenomenon by which chronic 
ethanol exposure likely elicits long-term alterations AIC functioning.  NMDARs that 
display sensitivity to acute ethanol inhibition generally enhance their functioning in 
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response to chronic ethanol exposure as a compensatory mechanism due to ethanol’s 
chronic inhibition, which results in aberrations from homeostatic NMDAR-dependent 
signaling processes (Roberto and Varodayan, 2017).  Prior research from our laboratory, 
among others, has shown that these long term alterations due chronic ethanol exposure 
lead to robust changes in expression of NMDAR-dependent plasticity states and ethanol-
related behavior (Abrahao et al., 2013; Jeanes et al., 2011; Jeanes et al., 2014).  Thus, our 
findings suggest that NMDARs and NMDAR-mediated signaling processes in layer 2/3 
AIC pyramidal neurons are ethanol-sensitive targets likely to underlie alterations in AIC 
function after chronic ethanol exposure.  Since layer 2/3 is the intracortical processing 
layer of the AIC, our data suggest that general intracortical processing in the AIC as well 
as its output to downstream brain regions are sensitive to disruption by chronic ethanol. 
In order to test the sensitivity of AMPAR-mediated glutamatergic transmission to 
ethanol, we examined whether evoked AMPAR-mediated currents were sensitive to 
ethanol.  Our investigation found that evoked AMPAR-currents were insensitive to 
intoxicating concentrations of ethanol, except for a non-statistically significant delayed 
enhancement nearly twenty minutes after the initial bath application of ethanol at a 
concentration nearly lethal (80 mM) to intolerant individuals.  As such, these negative 
results on evoked AMPAR-mediated currents are indicative of a selective postsynaptic 
action of ethanol.  However, as a final test of ethanol action on presynaptic glutamate 
release, we measured whether acute ethanol modulated sEPSCs.  We found that the 
significantly intoxicating concentration of ethanol (50 mM) did not change the mean 
frequency or mean amplitude of sEPSCs, indicative of no changes in glutamate release 
probability. 
In summary, these findings contribute to the abundance of literature indicating that 
the effects of acute ethanol on glutamatergic transmission in brain slice preparations are 
brain-region specific and concentration dependent.  Acute ethanol has been shown to 
generally reduce glutamatergic transmission (Lovinger and Roberto, 2013).  However, 
investigations of acute ethanol on glutamatergic transmission in some brain regions such 
as the ventral tegmental area, somatosensory cortex, and central amygdala show an ethanol-
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induced enhancement of glutamatergic transmission (Lu and Yeh, 1999; Xiao et al., 2009; 
Silberman et al., 2015; Herman et al., 2016).   
Ethanol has little action on GABAA transmission 
Similar to the glutamate system, modulatory effects of ethanol on GABAA-
mediated transmission in brain slice preparations have depended upon the brain region 
investigated as well as the ethanol concentration used (Nie at al., 1994, Roberto et al., 
2004, Lu and Yeh, 1999).  Acute ethanol has generally, but not always been shown to 
increase GABAergic transmission by both pre and postsynaptic mechanisms (Siggins et 
al., 2005; Lovinger and Roberto, 2013).  However, some studies have shown that 
GABAergic transmission in cortical regions is relatively insensitive to acute ethanol 
(Proctor et al., 1992; Soldo et al., 1998, Weitlauf and Woodward, 2008).  The current 
investigation did not show any effects of ethanol on spontaneous GABAA-mediated 
transmission.  We therefore conclude from our investigation that an intoxicating 
concentration of ethanol has little, if any, effect on spontaneous GABAA-mediated 
transmission onto layer 2/3 AIC pyramidal neurons.  
Ethanol disrupts NMDAR-dependent synaptic plasticity 
Since the disrupted processing of interoceptive stimuli has been suggested to play 
a role in drug and alcohol use disorders, and synaptic plasticity mechanisms are accepted 
as underlying aspects of learning and memory, we wished to investigate the effect of 
ethanol on long-term synaptic plasticity in intracortical processing layers of the AIC.  We 
initially found that acute ethanol inhibits NMDARs in the AIC, and so we hypothesized 
that any NMDAR-dependent long-term synaptic plasticity measures onto layer 2/3 AIC 
pyramidal neurons would likely be disrupted by acute ethanol.  Therefore, we 
investigated LTD as a long term synaptic plasticity mechanism onto layer 2/3 AIC 
pyramidal neurons. 
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Synaptic plasticity mechanisms are the means by which neural networks adapt to 
strengthen and weaken their connections to form the basis of information storage and are 
thought of as mechanisms of learning and memory (Kauer and Malenka, 2007; Kandel et 
al., 2014).  Such synaptic plasticity mechanisms in mesolimbic, addiction-relevant brain 
regions have been shown to be disrupted by drug experience and are thought to encode 
for and contribute to future drug and alcohol use (Luscher and Malenka, 2011; Lovinger 
and Kash, 2015).  Since the AIC and its output have been shown, in animal models, to be 
involved in more advanced, pathological forms of alcohol drinking, we reasoned that 
ethanol-induced changes in AIC processing and its output may mediate the changes in 
interoceptive functioning that are implicated in AUD.  Therefore, we decided to 
investigate plasticity mechanisms in AIC layer 2/3 pyramidal neurons. We performed the 
first demonstration of LTD using whole cell configuration in the IC.  Using a 1 Hz, low-
frequency stimulation protocol, we found a reduction in EPSC magnitude (LTD) of 
approximately 34%.  This form of LTD was NMDAR-dependent and likely mediated by 
a postsynaptic mechanism.  Since prior investigation in this study had determined an 
inhibitory effect of ethanol on NMDARs in AIC 2/3 pyramidal neurons, we reasoned that 
ethanol may, through its actions on NMDARs, inhibit the expression of our discovered 
NMDAR-dependent LTD mechanism.  We found that AIC LTD was similarly inhibited 
by several intoxicating concentrations of acute ethanol (20, 40, 60 mM), indicating that 
this NMDAR-dependent plasticity state is highly sensitive to intoxicating concentrations 
of ethanol. 
It is noteworthy that while 20 mM ethanol prevented the expression of LTD, this 
concentration of ethanol did not inhibit evoked NMDAR-mediated currents.  We suggest 
there are at least three reasons why this could be so.  First of all, the difference in ACSF 
Mg2+ concentration between LTD experiments (1.2 mM) and evoked NMDAR-mediated 
current experiments (1.0 mM) suggests that NMDARs were sensitive to lower 
concentrations of ethanol in LTD experiments than in evoked NMDAR-mediated 
experiments, as higher Mg2+ concentrations increase the sensitivity of NMDARs to 
ethanol (Ron and Wang, 2009).  Secondly, it is possible that ethanol inhibits our 
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uncovered form of synaptic plasticity via an alternative molecular target than NMDARs.  
Ethanol in acute preparations has a wide array of molecular targets, and has been shown 
to inhibit the expression of forms of LTD via its inhibitory action on synaptic 
metabotropic glutamate receptors (mGluRs) (Belmequenai et al., 2008; Carta et al., 2006; 
Su et al., 2010; Zorumski et al., 2014).  Generally, the major postsynaptic forms of LTD 
have been shown to be either NMDAR or mGluR-dependent, but some require both 
NMDARs and mGluRs (Collingridge et al., 2010).  Therefore, it is possible that our 
uncovered form of AIC LTD was additionally mGluR-dependent, and that acute ethanol 
inhibited its expression, at least in part, via its inhibitory actions on mGluRs.  Finally, 
NMDARs have metabotropic actions; thus it is possible that this APV-sensitive LTD is 
not mediated by ion flux (Dore et al., 2016). 
AIC synaptic plasticity, pain, and alcohol use disorder 
Recent research suggests that the neurobiological substrates for pain disorders 
and addiction overlap, and that adaptations in brain regions involved in chronic pain 
contribute to alcohol use disorder (Egli et al., 2012).  Multiple animal models have 
implicated NMDAR-depending signaling processes in the INS as targets encoding for 
chronic pain: The ability to induce INS NMDAR-dependent long-term potentiation and 
the ability to induce INS NMDAR-dependent LTD in ex vivo slice preparations were 
each shown to be lost in animal models of chronic pain (Qiu et al., 2013; Liu and Zhuo, 
2014).  This evidence of disrupted INS NMDAR-dependent signaling processes in 
chronic pain considered alongside ethanol’s widely demonstrated disruption of NMDAR-
dependent signaling processes suggests that NMDAR-dependent signaling processes in 
the INS may be shared mechanisms by which both pain and ethanol change INS function.  
In the present work, we verified that layer 2/3 of the AIC is an additional region in which 
acute ethanol modulates NMDAR function, and we observed that NMDAR-dependent 
plasticity in the AIC is sensitive to intoxicating concentrations of ethanol used to develop 
alcohol dependence in animal models.  Thus, together these findings suggest that 
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processing in the AIC is sensitive to acute ethanol disruption, and that synaptic 
mechanisms thought to mediate pain-related interoceptive changes in the AIC can also 
be disrupted by acute ethanol.  This is the initial investigation of the molecular 
mechanisms by which alcohol exposure may change healthy AIC functioning in the 
development of AUD. 
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Chapter 3:   
Chronic Ethanol Experience Modulates Glutamatergic Synaptic Transmission in 
the Agranular Insular Cortex  
This chapter written in the style for submission to Frontiers in Pharmacology  
Authors: Joel Shillinglaw, Heather Aziz, Daniela Carrizales, Richard A. Morrisett, 
Regina A. Mangieri. Joel Shillinglaw, Richard Morrisett, and Regina Mangieri conceived 
and designed experiments.  Joel Shillinglaw performed the experiments.  Joel Shillinglaw 
analyzed the data and interpreted the results.   Joel Shillinglaw and Regina Mangieri wrote 
the paper.  Heather Aziz conducted breeding of animals and assisted with animal 
behavior.  Daniela Carrizales assisted with animal behavior.    
 
ABSTRACT   
The Agranular Insular Cortex (AIC) is implicated in alcohol use disorder (AUD), 
and pharmacologically relevant concentrations of acute ethanol modulate N-methyl-D-
aspartate receptor (NMDAR)-mediated glutamatergic synaptic transmission and plasticity 
onto layer 2/3 AIC pyramidal neurons.  However, despite this evidence indicating 
NMDAR-dependent signaling is a synaptic target for acute ethanol in the AIC, it is not 
known whether NMDAR-dependent synaptic plasticity is a target by which chronic ethanol 
alters AIC function as alcohol drinking transitions from controlled to problematic.  
Therefore, we utilized the Chronic Intermittent Ethanol (CIE) vapor exposure model to 
model chronic ethanol exposure in adult male mice, and then tested for the expression of 
NMDAR-dependent long-term depression (LTD) of AMPAR-mediated signaling onto 
layer 2/3 AIC pyramidal neurons.  The ability to induce LTD ex vivo was inhibited by 
limited CIE exposure, but not equivalent chambering experience with air.  Groups that 
underwent extended exposure to ethanol via three bouts of CIE or Air, coupled with 
volitional ethanol drinking, no longer displayed LTD.  We tested for the expression of LTD 
in an ethanol-naïve group of mice of the same age at which extended exposure to ethanol 
experiments were conducted (≥14 weeks), and were unable to induce LTD, indicating AIC 
NMDAR-dependent LTD is an age-sensitive phenomenon.  We next tested whether 
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extended exposure to ethanol modulates other glutamatergic synaptic properties, and found 
that the ratio of NMDAR to α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid-type 
receptor (AMPAR)-mediated EPSCs to be reduced in Drinking + CIE relative to Drinking 
+ Air groups.  In a follow-up investigation, we found that ethanol exposure (Drinking + 
CIE & Drinking + Air groups) reduced the NMDAR/AMPAR relative to an ethanol-naïve, 
handling & age-matched control group.  Taken together these data indicate that 
glutamatergic transmission in the AIC is sensitive to chronic ethanol, and that changes in 
glutamatergic signaling in the AIC may occur by even moderate alcohol drinking.  
Moreover, these data add to the growing body of literature indicating that some synaptic 
mechanisms of learning and memory are at least partially age-dependent processes, which 
should be considered during the design and interpretation of experiments. 
INTRODUCTION 
The Agranular Insular Cortex (AIC) is involved in interoceptive processing, and 
deficits in AIC functioning and interoceptive processing are implicated in alcohol use 
disorder (AUD) (Craig et al., 2002; Craig et al., 2009; Naqvi and Bechara., 2010; Paulus 
and Stewart, 2014; Ateş Çöl et al., 2016).  Despite evidence for altered AIC functioning 
and/or output in animal models of AUD (Seif et al., 2013; Jaramillo et al., 2016; Jaramillo 
et al., 2017; Jaramillo et al., 2018), there has been minimal investigation of the effects of 
ethanol on synaptic transmission in the AIC.  The synaptic effects of ethanol in brain 
regions of addiction-relevance contribute to various neural and behavioral components of 
AUD (Lovinger and Roberto, 2013).  Recent research from our laboratory has 
demonstrated that N-methyl-D-aspartate receptor (NMDAR)-mediated synaptic 
transmission and plasticity onto AIC layer 2/3 pyramidal neurons is sensitive to acute 
ethanol at concentrations achieved during alcohol drinking (Shillinglaw et al., 2018). 
Prior work in several brain regions has shown that chronic ethanol produces long-
term alterations in the synaptic targets of acute ethanol (Lovinger and Roberto, 2013; 
Roberto and Varodayan, 2017).  Moreover, the long-term alterations in the functioning of 
synaptic receptors have been shown to encode for altered brain function and alcohol-related 
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behavioral phenotypes such as dependence and tolerance (Jeanes et al., 2011; Renteria et 
al., 2016; Lovinger & Kash., 2015; Lovinger and Roberto, 2013).  We hypothesized that 
NMDAR-dependent synaptic plasticity is a target by which chronic ethanol exposure 
disrupts AIC functioning, and therefore interoceptive processing, over the development of 
AUD. 
For these reasons we utilized the Chronic Intermittent Ethanol (CIE) Exposure Model 
to model in vivo chronic ethanol exposure in mice, and then tested whether CIE modulates 
NMDAR-dependent synaptic plasticity onto layer 2/3 AIC pyramidal neurons.  The ability 
to induce LTD was inhibited by limited CIE experience.  We then wished to determine 
whether ethanol experience sufficient to enhance volitional alcohol drinking and produce 
ethanol dependence and withdrawal modulates NMDAR-dependent plasticity (Becker and 
Lopez 2004; Griffin et al., 2014; Griffin et al., 2009; Renteria et al., 2018).  Therefore, we 
tested whether extended CIE (3-bouts) coupled to volitional two-bottle choice (2BC) 
drinking (Drinking + CIE) differentially modulates NMDAR-mediated synaptic plasticity 
relative to an identically treated group but with no CIE exposure (Drinking + Air).  
Drinking + CIE and Drinking + Air groups both displayed the inability to induce LTD.  
Since age has been shown to modulate the expression of different types of glutamatergic 
synaptic plasticity, we tested for the expression of LTD in an ethanol-naïve group of mice 
at the same age at which extended exposure to ethanol experiments were conducted (≥14 
weeks), and found we were unable to induce LTD.  We additionally tested whether 
extended exposure to CIE alters non NMDAR-mediated prominent glutamatergic 
electrophysiological properties (Renteria et al., 2017; Renteria et al., 2018; Hopf and 
Mangieri, 2018).  We found that Drinking + CIE and Drinking + Air groups showed no 
difference in paired pulse ratio or rectification index, but that the Drinking + CIE group 
showed a decreased NMDA/AMPA ratio relative to the Drinking + Air group.   
In order to validate this finding, as well as investigate whether drinking even 
moderate amounts of ethanol drinking alter NMDA/AMPA ratios, we replicated the 
extended exposure experiment with an additional ethanol-naïve, handling & age-matched 
control group.  We found that Drinking + CIE and Drinking + Air groups displayed a 
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reduction in NMDA/AMPA ratio relative to the ethanol-naïve, handling & age-matched 
control group.  These findings demonstrate that glutamatergic synaptic transmission in 
the AIC is sensitive to chronic ethanol, and suggest that even small amounts of alcohol 
drinking may alter glutamatergic synaptic transmission in the AIC.  These findings also 
add to the literature indicating that aspects of synaptic physiology are age-dependent 
beyond the transition into early adulthood, and that the age of mice, even beyond the 
onset of adulthood, should be considered in experimental design (McCutcheon and 
Marinelli, 2009; Jackson et al., 2017).   
Methods   
MICE 
Drd1a-tdTomato BAC transgenic male mice (MMRRC:030512-UNC) were used 
for all experiments.  Drd1a-tdTomato mice (Ade et al., 2011; initial breeding pairs obtained 
from The Jackson Laboratory, Stock No. 016204) were generated by backcrossing mice 
onto a C57BL/6J background in which only one parent carried the Drd1a-tdTomato 
transgene (Mangieri et al., 2017).  Mice were housed in standard cages (7.5” x 11.5” x 5”) 
with Sani-Chips wood bedding (PJ Murphy) at 22°C with a 12:12 light: dark cycle (lights 
off at 9:30AM).  Water and standard chow (LabDiet®5LL2 Prolab RMH1800) were 
available ad libitum, and all experimental procedures were approved by the University of 
Texas Institutional Animal Care and Use Committee. 
CHRONIC INTERMITTENT ETHANOL EXPOSURE 
For all CIE experiments (limited & extended), mice underwent exposure to ethanol 
vapor using the Becker-Lopez chronic intermittent ethanol (CIE) exposure model.  Mice 
were exposed to ethanol via the CIE exposure model, a well-validated passive exposure 
model which has been shown to induce intoxicating blood alcohol concentrations over 
extended amounts of time.  Briefly, a stock solution of 95% ethanol was placed inside 
 52 
sealed flask and volatized by bubbling air.  The resulting ethanol vapor was combined with 
an additional stream of air which was delivered to mice contained in mouse vapor chamber 
units containing an airtight top, a vapor inlet, and an exhaust outlet (Allentown Inc., 
Allentown, NJ).  Mice received intraperitoneal injections of a loading dose of ethanol (20% 
v/v, 1.5g/kg) and pyrazole (1 mM, 68.1 mg/kg) in phosphate buffered saline (PBS) 
immediately prior to placement in chamber units to obtain a target BEC of 150-200 mg/dl.  
Both doses and flow rates were adjusted to keep mice in target BEC range.  Air control 
mice were handled identically but injected with a solution of pyrazole in PBS before being 
placed into mouse vapor chamber units not connected an ethanol flask.  Ethanol-exposed 
mice were exposed to ethanol vapor for 16 hours followed by 8 hours of withdrawal, in 
which mice are not exposed to ethanol and blood ethanol concentrations (BEC) return to 
zero (data not shown).  This 4 consecutive day exposure period constitutes 1-bout of CIE.  
Limited CIE (1-bout) experiments were conducted 24 hours into withdrawal (Figure 13).  
Extended CIE (3-bout) experiments were conducted from 5-8 days to correlate 
glutamatergic changes with volitional ethanol consumption (Figures 14, 15, 16).  
BLOOD ETHANOL CONCENTRATIONS 
Immediately after each chambering day, tail blood samples were taken and BECs 
were calculated using a gas chromatograph (Bruker 430-GC) equipped with a flame 
ionization detector and CombiPAL autosampler (Bruker Corporation, Fremont, CA).  Two, 
5 µL tail blood samples were collected and added to two, 10 mL vials containing 45 µLs 
of saturated sodium chloride solution.  After samples were heated to 65 °C, ethanol vapor 
was absorbed from the samples with the solid-phase micro extraction fiber (SPME; 75 µm 
CAR/PDMS, fused silica; Supelco, Bellefonte, PA).  A capillary column was the stationary 
phase (30 m x 0.53 mm x 1 µm film thickness; Agilent Technologies, Santa Clara, CA), 
and helium was used in the mobile phase (at a flow rate of 8.5 mL/min).  CompassCDS 
Workstation software (Bruker Corporation, Fremont, CA) was used to analyze ethanol 
peaks, and external ethanol standards were used for calibration. 
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PREPARATION OF BRAIN SLICES 
Mouse brains were rapidly extracted and coronal slices containing the most anterior 
portion of the AIC were collected via established laboratory protocols (Shillinglaw et al., 
2018).  Briefly, mice were first anesthetized by inhalation of isoflurane and then euthanized 
by decapitation.  Brains were then quickly extracted from the skull and submerged in ice-
cold oxygenated artificial cerebrospinal fluid (ACSF) containing the following (in mM): 
210 Sucrose, 26.2 NaHCO3, 1 NaH2PO4, 2.5 KCl, 11 dextrose, bubbled with 95% O2/5% 
CO2.  Coronal slices (250 to 270 µm thick) containing AIC were collected using a Leica 
VT1000S vibrating microtome (Leica Corp., Bannockburn, IL), which were then placed 
into an incubation solution containing the following (in mM): 120 NaCl, 25 NaHCO3, 1.23 
NaH2PO4, 3.3 KCl, 2.4 MgCl2, 1.8 CaCl2, 10 dextrose, continuously bubbled with 95% O2/ 
5% CO2; 32°C, for at least 45 min for recovery prior to recording.   
Patch-Clamp Electrophysiology 
 
Whole cell recordings were taken from layer 2/3 pyramidal AIC neurons identified 
via morphology (large, pyramidal-like shape) using a MRK200 Modular Imaging system 
(Siskiyou Corporation, Grants Pass, OR) mounted on a vibration isolation table.  
Recordings were made in ACSF containing (in mM): 120 NaCl, 25 NaHCO3, 1.23 93 
NaH2PO4, 3.3 KCl, 1.2 MgSO4, 2.0 CaCl2, and 10 dextrose unless otherwise noted, 
bubbled with 94 95% O2/ 5% CO2; 32°C, controlled by an in-line bath heather (Warner 
Instruments, Hamden, CT).  Picrotoxin (50 µM) was included in the recording ACSF to 
block GABAA receptor-mediated synaptic currents.  Brain slices were perfused at a rate of 
2.0 mL/min.  A P-97 Flaming/Brown model micropipette puller (Sutter Instruments, San 
Rafael, CA) was used to make recording electrodes (thin-wall glass, WPI Instruments, 
Sarasota FL) of resistances from 3-6 MΩ.  For all experiments, recording electrodes were 
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filled with (in mM): 120 CsMeSO4, 15 CsCl, 8 NaCl, 10 HEPES, 0.2 EGTA, 10 TEA-Cl, 
4 Mg-ATP, 0.3 Na-GTP, 0.1 spermine, and 5 QX-314-Cl.  Series resistance (Rs) was 
monitored throughout each experiment, and cells with Rs of over 30 MΩ or that changed 
over 20% over the course of the experiment were excluded from the analysis.  One cell per 
brain slice was used for LTD experiments, and multiple cells per brain slice were 
sometimes used for other glutamatergic assays.  All chemicals were obtained from either 
Sigma-Aldrich or Tocris Bioscience with the exception of ethanol, which was obtained 
from Pharmco-Aaper.    
DATA ACQUISITION AND ANALYSIS  
An Axopatch 200B amplifier (Axon Instruments, Foster City, CA) was used to 
acquire all currents, which were filtered at 1 kHz, and digitized at 10-20 kHz via a Digidata 
1440A interface board using pClamp 10.2 (Axon Instruments).  Excitatory postsynaptic 
currents (EPSCs) were evoked with a stainless steel bipolar stimulating electrode 
(MX21AES, FHC, Inc., Bowdoin, ME, United States) placed approximately 500 µm 
dorsomedial to the cell body (Shillinglaw et al., 2018). For LTD experiments, EPSCs were 
evoked for at least 10 min (at 0.025 Hz) to ensure stable recordings, followed by a low-
frequency stimulation protocol consisting of 1 Hz stimulation of 15 min.  Evoked EPSCs 
were then monitored for a 30 min post-stimulation period at 0.025 Hz to test for the 
expression of LTD.  Neurons were held at -70 mV for the entirety of LTD experiments.  
Data were collapsed into 2 min bins and the expression of LTD was calculated by 
comparing the 20 to 30 min period after the low-frequency stimulation protocol to the 10 
min baseline period.  Statistical significance from baseline for within each treatment group 
was defined as p < 0.05 using a one-sample t test.  For paired-pulse ratios, ppr were 
acquired by applying two stimuli of equal intensity, separated by an interstimulus interval 
(ISI) of 50 ms and calculated as a ratio of EPSC 2/EPSC 1.    NMDA/AMPA ratios were 
calculated as the ratio of the EPSC recorded at +40 mV, 50 ms after stimulation (NMDA) 
and the peak EPSC recorded at -80 mV (AMPA).  Rectification index was calculated as 
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the EPSC amplitude at +40 mV/EPSC amplitude at -80 mV in the presence of 100 µM DL-
APV.  Group comparisons were made using a 1-way ANOVA and Bonferroni post hoc 
test.  Statistical significance for all experiments was defined as p < 0.05. 
 
RESULTS   
Sensitivity of LTD to limited CIE 
It has been shown that chronic ethanol modulates synaptic plasticity across multiple 
brain regions which encodes for behavioral aspects of AUD (Jeanes et al., 2011; McCool, 
2011; Abrahao et al., 2013; Lovinger and Kash, 2015).  Prior research from our laboratory 
has observed that even limited exposure to CIE (1-bout) induces robust alterations in the 
polarity of glutamatergic synaptic plasticity of medium spiny neurons in the nucleus 
accumbens shell in a cell-type specific manner (Jeanes et al., 2014; Renteria et al., 2016).  
Since the CIE model has shown that cycles of ethanol vapor generally result in enhanced 
volitional ethanol consumption, these results are taken to indicate that even limited CIE 
exposure is sufficient to alter glutamatergic synaptic plasticity mechanisms underlying 
aspects of escalated drinking, withdrawal, and dependence (Becker and Lopez, 2004; 
Griffin et al., 2009; Griffin, 2014; Lopez and Becker, 2005).  We therefore investigated 
whether limited CIE (1-bout) similarly modulates the expression of AIC glutamatergic 
LTD.  Layer 2/3 AIC pyramidal neurons prepared from mice 24 hours after limited CIE 
(1-bout) displayed differences in excitatory transmission in response to the low frequency 
stimulation paradigm (1 Hz for 15 min) previously shown to induce NMDAR-dependent 
LTD of evoked AMPAR-mediated EPSCs (Shillinglaw et al., 2018).  We found that LTD 
was produced in layer 2/3 AIC pyramidal neurons in ethanol-naïve air mice (Figure 13; 
one-sample t-test, t = 3.265, p = 0.0138).  However, using this same stimulation paradigm, 
we were unable to induce LTD in CIE mice 24 hours into withdrawal (Figure 13; one-
sample t-test, t = 0.680, p = 0.5118).  
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Sensitivity of LTD to extended CIE 
We additionally wished to determine whether extended CIE experience, which has 
been shown to enhance volitional ethanol drinking and produce ethanol dependence and 
withdrawal, differentially modulates LTD relative to an identical ethanol-drinking group 
without CIE experience (Becker and Lopez, 2004; Griffin et al., 2009; Griffin, 2014; Lopez 
and Becker, 2005).  Therefore, additional groups of mice underwent 3 bouts of either CIE 
or air exposure coupled with 2BC drinking sessions (Drinking + CIE and Drinking + Air 
groups, respectively; Figure 14).  Layer 2/3 AIC pyramidal neurons were recorded from 5-
8 days after the final CIE/Air bout to relate glutamatergic changes to the time point at which 
2BC drinking occurs (Figure 14).  The Drinking + CIE mice displayed the inability to 
induce LTD (Figure 2; one-sample t-test, t = 1.146, p = 0.2894).  Additionally, the Drinking 
+ Air mice displayed the inability to induce LTD (Figure 14; one-sample t-test, t = 1.162, 
p = 0.2834). 
 
Sensitivity of LTD to Age 
The absence of LTD in the Drinking + Air group was a surprise, as similar studies 
of NMDAR-LTD in the NAc found LTD was still present in Drinking + Air groups 
(Renteria et al., 2018; Kircher et al., 2019).  NMDAR-dependent LTD of AMPAR 
transmission in the AIC has not been extensively characterized and the prior work on this 
form of plasticity in the AIC was done using animals that were younger in age than that of 
the extended ethanol exposure experiment (Shillinglaw et al., 2018).  Thus, the absence of 
LTD in both the Drinking + CIE and the Drinking + Air group was unexpected.  Research 
has shown that synaptic physiology and the expression of plasticity can change over the 
course of an animal’s life from adolescence to adulthood, and even beyond the emergence 
of early adulthood (McCutcheon and Marinelli, 2009; Jackson et al., 2017; Barnes, 1979, 
Lynch et al., 2006; Foster, 1999).  Mice from the limited CIE (1-bout) experiment were 8-
11 weeks, and mice from the extended CIE (3-bout) experiment were at least 14 weeks of 
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age.  Therefore, as a control experiment, we tested whether we could reliably induce LTD 
onto AIC layer 2/3 pyramidal neurons in mice that were at least 15 weeks of age.  Low 
frequency stimulation onto layer 2/3 AIC pyramidal neurons prepared from ethanol-naïve 
mice of at least 15 weeks of age did not induce LTD (Figure 15; one-sample t-test, t = 
1.231, p = 0.2385). 
 
Sensitivity of other glutamatergic properties to extended CIE 
Since LTD was not reliably expressed in mice beyond early adulthood, we 
determined whether extended CIE experience differentially modulates other indices of 
glutamatergic synaptic transmission and plasticity relative to an identical ethanol-drinking 
group without CIE experience.  Therefore, additional groups of mice underwent 3-bouts of 
either CIE or Air exposure both coupled with 2BC drinking sessions (Drinking + CIE and 
Drinking + Air groups, respectively; Figure 16).  Layer 2/3 AIC pyramidal neurons were 
recorded from 5-8 days after the final CIE/Air bout to relate glutamatergic changes to the 
time point at which 2BC drinking occurs (Figure 16).  We found no differences in paired 
pulse ratio between Drinking + CIE and Drinking + Air mice (Figure 16; unpaired t-test, t 
= 0.07125, p = 0.9441).  We also found no differences in rectification index between 
Drinking + CIE and Drinking + Air mice (Figure 16; unpaired t-test, t = 1.21, p = 0.2364).   
Finally, we wished to observe whether there were any changes in NMDA/AMPA ratio.  
We did, however, observe a significant reduction in the NMDA/AMPA ratio in the 
Drinking + CIE relative to the Drinking + Air mice (Figure 16; unpaired t-test, t = 2.932, 
p = 0.0098). 
 
Sensitivity of NMDA/AMPA to Handling + Air, Drinking + Air, and Drinking + CIE 
Since this is the initial investigation of chronic ethanol on glutamatergic 
transmission the AIC, we wished to validate our reduced NMDA/AMPA ratio by 
replicating this finding in additional groups of mice.  We also wished to determine whether 
drinking ethanol for weeks without CIE as conducted in the Drinking + Air groups alters 
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NMDA/AMPA ratios relative to ethanol-naïve mice.  Therefore, we replicated the 
extended CIE experiment with additional groups of Drinking + Air and Drinking + CIE 
mice, along with a concurrent ethanol-naïve Handling + Air control group.  We observed 
a statistically effect of group (Figure 17; one-way ANOVA, F(2, 27) = 0.4457, p = 0.0110].  
However, we did not observe any differences between Drinking + Air and Drinking + CIE 
groups using a Bonferroni post hoc multiple comparisons test. It is therefore possible that 
any glutamatergic alterations in the AIC could occur due to non-pathological ethanol 
drinking rather than CIE-induced dependence.   
 
Figure 13.  Limited exposure to CIE inhibits the ability to induce LTD at 
glutamatergic synapses onto AIC layer 2/3 pyramidal neurons. 
 
 
Figure 13.  Limited exposure to CIE exposure inhibits the ability to induce LTD at 
glutamatergic synapses onto AIC layer 2/3 pyramidal neurons. (A) Representative traces 
from a single neuron of each group showing evoked EPSCs before and 20-30 min after 
conditioning stimulation protocol (900 pulses at 1Hz while holding the neuron at -70 
mV).  (B) Conditioning stimulation induces LTD expression in Air-treated, but not CIE-
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treated mice 24 hours into withdrawal (Air, n = 8 neurons/8 slices/8 mice, *p = 0.01 
compared to baseline; CIE, n = 11 neurons/11 slices/8 mice).  Values are expressed as 
averages ± S.E.M 
  
 
Figure 14.  Extended exposure to CIE and ethanol drinking does not alter the 
expression of NMDAR-mediated LTD relative to an Air and ethanol drinking 
control group in AIC layer 2/3 pyramidal neurons. 
 
 
Figure 14.  Extended exposure to CIE and ethanol drinking does not alter the expression 
of NMDAR-mediated LTD relative to an Air and ethanol drinking control group in AIC 
layer 2/3 pyramidal neurons.  (A) Conditioning stimulation does not induce LTD of evoked 
EPSCs onto AIC layer 2/3 pyramidal neurons of Drinking + Air or Drinking + CIE mice 
(Drinking + Air, n = 8 neurons/8 slices/6 mice; Drinking + CIE, n = 8 neurons/8 slices/7 
mice).  (B) Representative traces from a single neuron of each group showing evoked 
EPSCs before and 20-30 min after low-frequency conditioning stimulation protocol.  
Values are expressed as averages ± S.E.M.   
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 Figure 15.  Conditioning stimulation does not induce LTD at glutamatergic 
synapses onto AIC layer 2/3 pyramidal neurons in ethanol-naïve mice at least 14 
weeks old. 
 
 
Figure 15.  Conditioning stimulation does not induce LTD at glutamatergic synapses onto 
AIC layer 2/3 pyramidal neurons in ethanol-naïve mice at least 14 weeks old.  (A) 
Representative traces from a single neuron showing evoked EPSCs before and 20-30 min 
after low-frequency conditioning stimulation protocol.  (B) Conditioning stimulation did 
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not induce LTD expression in at least 15 weeks old (n = 15 neurons/15 slices/9 mice). 
Values are expressed as averages ± S.E.M. 
 
Figure 16.  Extended exposure to CIE and ethanol drinking reduces NMDA/AMPA 
ratio, but does not alter the expression of other prominent glutamatergic properties 
relative to an Air and ethanol drinking control group in AIC layer 2/3 pyramidal 
neurons. 
 
 
Figure 16.  Extended exposure to CIE and ethanol drinking reduces NMDA/AMPA ratio, 
but does not alter the expression of other prominent glutamatergic electrophysiological 
properties relative to an Air and ethanol drinking control group in AIC layer 2/3 pyramidal 
neurons.  (A) Paired Pulse Ratio (second evoked EPSC amplitude/ first evoked EPSC 
amplitude) does not change between Drinking + Air and Drinking + CIE mice (Drinking 
+ Air, n = 8 neurons/7 slices/7 mice; Drinking + CIE, n = 9 neurons/8 slices/4 mice).  (B) 
NMDA/AMPA Ratio (NMDAR component evoked at +40 mV and 50 ms after stimulus 
offset/AMPAR component evoked at -80 mV) is decreased in Drinking + CIE relative to 
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Drinking + Air mice (Drinking + Air, n = 9 neurons/9 slices/5 mice; Drinking + CIE, n = 
9 neurons/9 slices/5 mice, **p = 0.0098 vs Drinking + Air).  (C) No change is observed in 
the current voltage (IV) relationship of AMPAR mediated EPSCs (in the presence of 100 
µM DL-APV) between Drinking + Air and Drinking + CIE mice (Drinking + Air, n = 10 
neurons/10 slices/6 mice; Drinking + CIE, n = 6 neurons/6 slices/4 mice).  (D) No change 
in the rectification index (Evoked EPSC amplitude at +40 mV/EPSC amplitude at -80 mV 
in the presence of 100 µM DL-APV) is observed between drinking + Air and Drinking + 
CIE mice (Drinking + Air, n = 13 neurons/13 slices/6 mice; Drinking + CIE, n = 16 
neurons/15 slices/8 mice).  Values are expressed as averages ± S.E.M. 
 
Figure 17.  Extended ethanol drinking reduces NMDA/AMPA ratio relative to an 
ethanol-naïve, age-matched and handling control group in AIC layer 2/3 pyramidal 
neurons. 
 
 
Figure 17.  Extended ethanol drinking reduces NMDA/AMPA ratio relative to an ethanol-
naïve, age-matched and handling control group in AIC layer 2/3 pyramidal neurons.   (A) 
Representative traces from a single neuron of each group showing evoked NMDA/AMPA 
Ratio (NMDAR component evoked at +40 mV and 50 ms after stimulus offset/AMPAR 
component evoked at -80 mV).  (B) NMDA/AMPA Ratio is decreased in Drinking + CIE 
mice relative to Handling + Air mice (Handling + Air, n = 14 neurons/9 slices/5 mice; 
Drinking + Air, n = 8 neurons/5 slices/2 mice; Drinking + CIE, n =8 neurons/4 slices/3 
mice; *p = 0.01 vs. Handling + Air. Values are expressed as averages ± S.E.M.  
Discussion  
AIC LTD is sensitive to limited CIE 
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Chronic ethanol exposure has been shown to disrupt the healthy functioning of 
cortical regions via its long-term neuroadaptations to the electrophysiological properties of 
neurons (Kroener et al., 2012; Pleil et al., 2015; Nimitvilai et al., 2016).  These 
neuroadaptations are thought to potentially reveal how various cognitive disruptions 
observed in individuals with AUD, such as deficits in response inhibition and reversal 
learning, occur (Kroener et al., 2012; Nimitvilai et al., 2016).  It has been shown that 
alterations in AIC functioning and interoception are involved in aspects of AUD (Naqvi 
and Bechara, 2010; Paulus and Stewart, 2014; Ateş Çöl et al., 2016).  Therefore, since our 
previous investigation showed that NMDAR-dependent synaptic transmission and 
plasticity are targets for acute ethanol, we tested whether the chronic actions of ethanol on 
NMDAR-dependent synaptic plasticity is a mechanism by which chronic ethanol alters 
AIC function. 
We found that limited (1-bout) CIE inhibits the ability to induce LTD onto AIC layer 
2/3 pyramidal neurons 24 hours into withdrawal (Figure 13).  Since the Becker-Lopez CIE 
model reliably produces aspects of AUD, we hypothesized that disruptions in NMDAR-
dependent LTD may be a signature of altered AIC functioning and interoception as ethanol 
consumption shifts from controlled to problematic (AUD-like).  Such a finding wound not 
be without precedence, as several investigations have found disruption of NMDAR-
dependent plasticity in brain regions of addiction interest that are related to ethanol-related 
behavior (McCool 2011; Abrahao et al., 2013; Jeanes et al., 2011; Jeanes et al., 2014; 
Renteria et al., 2017).  However, it was also possible that the disruption in AIC LTD is not 
related to ethanol-related behavior, and rather a more general effect of ethanol withdrawal 
unrelated to the pathology of AUD.  Indeed, Spiga and colleagues first suggested that the 
disruption of NMDAR-dependent LTD might be a ubiquitous mechanism at excitatory 
synapses across several brain regions as a consequence of ethanol withdrawal (Spiga, 
2014). 
AIC LTD is age-sensitive 
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We wished to better determine whether the disruption of AIC NMDAR-dependent 
LTD is linked to ethanol-related behavior.  We next tested whether extended ethanol 
experience with the Becker-Lopez CIE model reliably shown sufficient to produce 
behavioral aspects of AUD differentially modulates NMDAR-dependent LTD from mice 
that drink ethanol without behavioral aspects of AUD (Becker and Lopez 2004; Griffin et 
al., 2014; Griffin et al., 2009; Renteria et al., 2017).  To do so, mice that drank ethanol 
were either given 3-bouts of exposure to CIE (Drinking + CIE) or 3-bouts of exposure to 
Air (Drinking + Air) and tested ex vivo for the expression of LTD (Figure 14).  Previous 
investigations from our laboratory have shown that withdrawal from CIE switches the 
polarity of synaptic plasticity from LTD to long-term potentiation (LTP) due to enhanced 
NMDAR functioning in the nucleus accumbens shell (Jeanes et al., 2011; Jeanes et al., 
2014; Renteria et al., 2016).  Therefore, we hypothesized that several bouts of CIE would 
result in either the continued inability to induce LTD, or the switch in polarity of plasticity 
to long-term potentiation (LTP) in Drinking + CIE mice.  Since Drinking + Air mice would 
not undergo bouts of chronic ethanol vapor, we predicted that Drinking + Air mice would 
express LTD.  We found, surprisingly, that both Drinking + CIE and Drinking + Air groups 
no longer displayed LTD in response to conditioning stimulation (Figure 14).   
The absence of LTD in both groups was indeed unexpected, and could occur due to 
several reasons.  However, one preliminary difference we wished to rule out between the 
limited and extended exposure experiments was the age difference between mice.  Mice in 
the limited, 1-bout CIE exposure LTD experiment ranged from 8-11 weeks of age and mice 
extended access experiment were ≥14 weeks.  There is a wealth of literature indicating that 
synaptic properties are at least partly age-dependent (McCutcheon and Marinelli, 2009; 
Jackson et al., 2017).  It is generally thought that adulthood starts for mice around week 8, 
and so at first impression the differences in using mice from different periods of adulthood 
may not appear important for experimental design (Spear, 2000; Laviola et al., 2003).  
However, there is evidence that synaptic effects change even over the course of adulthood 
(Barnes, 1979, Lynch et al., 2006; Foster, 1999).  Moreover, we were the initial group to 
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uncover AIC NMDAR-dependent LTD in whole-cell configuration, and did not initially 
test for age-dependent plasticity effects.  In ethanol-naïve mice that were at least 15 weeks 
old, we no longer observed LTD, indicating that the ability to induce AIC NMDAR-
dependent LTD is, at least in part, an age-dependent phenomenon (Figure 15).  Therefore, 
using the Becker-Lopez model of extended ethanol exposure and drinking with mice of ≈ 
15 weeks of age for our LTD assay is not an appropriate test to perform after this model of 
extended ethanol exposure. 
 
Extended chronic ethanol exposure and ethanol drinking reduce AIC NMDA/AMPA 
 
Since our LTD assay was not feasible for determining differences in glutamatergic 
synaptic transmission in mice of ≈ 15 weeks, additional indices of glutamatergic synaptic 
transmission and plasticity were conducted.  We found that Drinking + CIE mice show a 
significantly reduced NMDA/AMPA ratio relative to Drinking + Air mice.  Since exposure 
to chronic ethanol has frequently been shown to enhance glutamatergic transmission via 
increasing NMDAR function and NMDAR-mediated signaling, we were initially surprised 
by this finding (Lovinger and Roberto, 2013; Cebers et al., 1999; Grover et al., 1998; Gulya 
et al., 1991; Roberto and Varodayan, 2017).  Moreover, although there is evidence that 
chronic ethanol enhances the expression and functioning of AMPA receptors, it has 
generally been shown to be at a lower level than that of NMDA (Lovinger and Roberto, 
2013; Smothers et al., 1997; Chandler et al., 1997; Roberto and Varodayan, 2017).  
Therefore, at initial glance, our findings were perplexing as we expected to observe an 
enhanced NMDA/AMPA ratio due to increased NMDAR expression and function 
accompanied by potential, but less significant, changes in AMPAR expression and 
function.  However, additional demonstrations are showing that the effects of chronic 
ethanol on postsynaptic glutamate receptors depend upon the brain region investigated and 
the time point after ethanol withdrawal (Kroener et al., 2012; Kim et al., 2014; Trantham-
Davidson et al., 2014; Mcguier et al., 2015; Nimitvilai et al., 2016). 
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Since chronic ethanol has been shown to alter AMPAR-dependent aspects of 
glutamatergic synaptic transmission, we also wished to determine whether extended CIE 
exposure with ethanol drinking modulates aspects of AMPAR-dependent glutamatergic 
synaptic transmission onto the AIC (Hopf and Mangieri, 2018).  Acute ethanol is generally 
accepted to be an inhibitor of excitatory signaling, while chronic ethanol has been shown 
to increase excitatory drive by increasing glutamatergic transmission onto neurons 
(Lovinger and Roberto, 2013).  We found that chronic ethanol did not change paired pulse 
ratios (PPR) at a 50 ms interval, indicating that chronic ethanol exposure with ethanol 
drinking does not alter glutamate release probability onto AIC 2/3 pyramidal neurons.  As 
a final assay of glutamatergic changes, we tested for changes in the rectification index to 
determine whether there were differences in the expression of calcium-permeable AMPA 
receptors (CPARS) which have been shown to be increased in the nucleus accumbens and 
implicated in motivational aspects of AUD such as craving.  We found no changes in the 
I/V curve or rectification index, indicating no changes in the expression of CPARs. 
Additional follow-up electrophysiological studies of isolated NMDAR-mediated and 
AMPAR-mediated input-output curves to determine which component of the 
NMDA/AMPA ratio is changed at this timepoint is warranted.  Additionally, 
complementary investigations of biochemical data to determine whether changes in 
glutamatergic NMDAR and AMPAR subunit composition accompany this investigation 
are also warranted. 
Our main finding was that drinking ethanol alters the NMDA/AMPA ratio, a 
commonly used index of glutamatergic synaptic transmission and plasticity, onto layer 2/3 
AIC pyramidal neurons.  Therefore, it is likely that any synaptic changes onto layer 2/3 
AIC pyramidal neurons occur during the initial aspects of ethanol drinking before extended 
ethanol exposure may occur.  It is important to relate the glutamatergic synaptic plasticity 
effects observed due to even moderate (Drinking + Air) ethanol exposure in this experiment 
with the literature referencing the behavioral manifestations of glutamatergic synaptic 
plasticity mechanisms in the cortex.  For example, glutamatergic synaptic plasticity 
mechanisms in the INS have been shown to encode for phenotypes produced by models of 
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neuropathic pain, as well as regulate the rate of conditioned taste aversion learning (Qiu et 
al., 2013; Liu and Zhuo, 2014; Rodríguez-Durán et al., 2017).  From this point of view, it 
would be an invaluable investigation to determine whether the glutamatergic synaptic 
changes due to ethanol exposure even from our limited (Drinking + Air) paradigm are 
enough to modulate the expression of neuropathic pain as well as the extinction of 
conditioned taste aversion (Qiu et al., 2013; Liu and Zhuo, 2014; Rodríguez-Durán et al., 
2017).  Moreover, ethanol has well-documented aversive properties, and the reduction of 
the aversive aspects of ethanol consumption have been increasingly recognized as a 
component of the addition cycle for ethanol.  It has been shown that a single 24 hour 
experience two-bottle choice paradigm enhances ethanol consumption adulterated with the 
bitter tastant quinine, but that it does not change quinine palatability (Lei et al., 2016). 
Therefore, it could be that ethanol exposure, at even early, moderate levels, disrupts 
glutamatergic synaptic plasticity mechanisms in the INS that encode for aversive 
interoceptive mechanisms including, but not limited to, alcohol consumption.    
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Chapter 4:  
Concluding remarks and future directions  
 The findings in this dissertation are the first piece of evidence that the AIC is a 
direct synaptic target for the actions of ethanol.  Of the major components of GABAergic 
and glutamatergic synaptic transmission, NMDAR-type glutamatergic transmission is 
sensitive to pharmacologically relevant concentrations of acute ethanol.  The 
NMDA/AMPA ratio, a marker for glutamatergic synaptic strength and plasticity, is altered 
by even limited ethanol consumption.  Together these data indicate that the AIC is an 
ethanol-sensitive brain region in which changes during exposure to ethanol are likely to 
occur.       
There is a great need to better understand how the brain adapts to conditions that 
produce aspects of AUD.  Despite several years of preclinical research investigating the 
neural mechanisms underlying aspects of AUD, there are still few effective 
pharmacotherapies for AUD treatment.  More basic research investigating how neural 
circuits of motivational valence become disrupted over the development of AUD will 
likely lead to treatment targets, and more efficacious treatment compounds.  To that effect, 
there needs to be a more comprehensive investigation of how chronic ethanol changes 
brain regions and circuits implicated in the three stages of the addiction cycle: 1) 
binge/intoxication of ethanol exposure, 2) ethanol withdrawal, and 3) 
preoccupation/anticipation with ethanol.   
It is generally accepted that the development of addiction occurs over iterations of 
a three-stage, interdependent cycle: Initial ethanol use to binge/intoxication levels in 
which use is maintained by positive reinforcement mechanisms, withdrawal/negative 
affect in which the absence of ethanol produces negative affective states such as anxiety 
and dysphoria, and preoccupation/anticipation stage in which the motivation for ethanol 
drinking becomes increasingly ubiquitous in an individual’s life (Koob et al., 2014).  
Individuals within the preoccupation/anticipation stage are therefore more likely to begin 
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drinking ethanol to binge/intoxicating levels, and thus begin the cycle again.  Several 
cycles over time are generally accepted to generate, at least in part, an AUD.  For this 
reason it is vital to comprehensively investigate how alcohol changes brain regions and 
circuits implicated in each aspect of the addiction cycle. 
While a comprehensive review of the pharmacological effects of ethanol on brain 
circuits implicated in each aspect of AUD is outside the scope this dissertation, it can be 
summarized as follows: Initial ethanol use to binge/intoxicating levels is thought to be 
maintained via brain structures connected by the medial forebrain bundle reward system 
with focus on the ventral tegmental area, nucleus accumbens, amygdala, prefrontal cortex, 
and hippocampus (Koob et al., 2014).  Dopaminergic afferents from the ventral tegmental 
area to these structures, termed the “reward circuit,” have been implicated in the rewarding 
and positive reinforcing aspects of several drugs of abuse, including ethanol.  Withdrawal 
from binge ethanol places the individual within the withdrawal/negative affect stage, in 
which neuroadaptations occur in some of these same brain structures as well as brain 
regions implicated in anxiety and dysphoria such as the bed nucleus of the stria terminalis 
and the extended amygdala.  After repeated cycles of binge and withdrawal, glutamatergic 
afferents from cortical regions onto these midbrain structures play a large role in advanced 
aspects of AUD in the preoccupation/anticipation stage of ethanol use. 
Until recently, despite evidence for altered INS activity and interoception in 
individuals with AUD, the INS has been largely overlooked by researchers investigating 
the addiction cycle (Naqvi and Bechara, 2010; Ateş Çöl et al., 2016).   Animal research has 
suggested that the INS and disrupted interoceptive states contribute to the addiction cycle 
for AUD in a multidimensional manner (Pushparaj et al., 2015; Jaramillo et al 2016; 
Jaramillo et al., 2017; Jaramillo et al 2018; Naqvi and Bechara, 2010).  Since chronic 
ethanol has been shown to contribute to AUD via disrupting homeostatic brain functioning 
in other brain regions, our overarching hypothesis was that chronic ethanol may disrupt 
INS processing and promote aspects of AUD. 
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While it had been determined that the INS has a role in the behavioral actions of 
ethanol, it had not yet been determined whether the INS is a direct target for ethanol’s 
actions (Pushparaj et al., 2015; Jaramillo et al 2016; Jaramillo et al., 2017; Jaramillo et al 
2018).  Historically, elucidating the pharmacology of ethanol has proven difficult; its 
molecular structure yields low binding affinity for several cellular components.  However, 
more recent research has shown its main behavioral mechanism of action to be via its 
actions on various ethanol-sensitive proteins (Harris et al., 2008).  Despite a diverse set of 
ethanol-sensitive molecular targets, an extant body of research has indicated that the 
synapse is among the most sensitive of sites of ethanol’s actions.  This research indicates 
that a major component of the behavioral effects of ethanol is due to its actions on the 
ligand-gated ion channels responsible for major fast inhibitory and excitatory synaptic 
transmission, GABA and glutamate (Lovinger and Roberto 2013).  However, these 
synaptic effects of ethanol have shown to be both brain region and concentration 
dependent, ostensibly due to receptor subunit composition and ion channel phosphorylation 
state (Nie et al., 1994; Lovinger et al., 1990; Roberto et al, 2003; Weitlauf et al., 2008; 
Badanich et al., 2013; Lovinger and Roberto., 2013; Kash et al., 2008; Shillinglaw et al., 
2018). 
We therefore investigated whether synaptic components of GABAergic and 
glutamatergic transmission in the AIC were targets for acute ethanol.  We investigated the 
AIC subregion for several reasons.  Its chemoarchitecture contains addiction-relevant 
receptor systems, D1Rs and CRF1Rs, indicated in positive reinforcement as well as stress 
signaling.  Additionally, the AIC has reciprocal connections to limbic regions of significant 
relevance to AUD.  Moreover, glutamatergic efferents from the AIC to midbrain and limbic 
structures have been shown to mediate compulsive and relapse components of drugs of 
abuse (Seif et al., 2013; Venniro et al., 2017).  Of the cell types and layers of the AIC, we 
investigated layer 2/3 pyramidal neurons because layer 2/3 is typically considered the 
intracortical processing layer.   
We found NMDARs in the AIC are sensitive to ethanol at blood ethanol 
concentrations achieved while drinking ethanol, a phenomenon consistent with results 
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from several other brain regions (Ron and Wang, 2009).  Long-term changes in synaptic 
functioning are thought to be mechanisms of information storage and learning and memory 
in the central nervous system, and NMDARs have been shown to be major regulators of 
long-term information storage in the CNS (Kandel et al., 2014;).  Therefore, we suggested 
that NMDAR-dependent mechanisms of long-term information storage and memory in the 
AIC are sensitive to ethanol.  After generating and validating an NMDAR-dependent LTD 
in whole cell configuration, we determined that ethanol disrupted NMDAR-dependent 
mechanisms of information storage in the AIC at ≥ 20 mM.  Therefore, NMDAR-type 
glutamate transmission in the AIC is sensitive to acute ethanol. 
Chronic ethanol has been shown to produce long-term alterations in functioning of 
the synaptic targets of acute ethanol and involvement in AUD behavioral phenotypes.  
Therefore, we wished to investigate how chronic ethanol modulates NMDAR-dependent 
LTD in the AIC.  In an experiment designed to test the initial effects of chronic ethanol on 
LTD, we found that four days of ethanol vapor exposure was sufficient to disrupt NMDAR-
dependent LTD in layer 2/3 AIC pyramidal neurons 24 hours into withdrawal.  We 
concluded that since ethanol vapor exposure generates aspects of AUD, the disruption of 
AIC LTD may predict an AUD-like phenotype.  However, to fully test for differences in 
an AUD phenotype versus an ethanol drinking non-AUD drinking phenotype, we tested 
for differences in NMDAR-dependent LTD in CIE-treated (Drinking + CIE) vs. Air-treated 
(Drinking + Air) mice after extended bouts.  We found that both groups no longer displayed 
LTD.  In addition, we wished to test whether our NMDAR-dependent LTD mechanism 
was an age dependent phenomenon.  Mice in the 1 bout CIE study were from 8-11 weeks, 
and mice in the extended drinking paradigm were at least 14 wks.  We observed an inability 
to induce LTD in an additional group of ethanol naïve mice at least 14 weeks old, indicating 
this form of synaptic plasticity is at least partially an age-dependent phenomenon.  
Therefore, the aforementioned investigation of differences in LTD in Drinking + CIE vs. 
Drinking + Air mice is not valid. 
Since chronic ethanol has produced differences in several aspects of glutamatergic 
transmission in other brain regions, we then investigated whether other glutamatergic 
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electrophysiological parameters were modulated in low-risk (Drinking + Air) and AUD-
like (Drinking + CIE) mice.  We found that the NMDA/AMPA ratio was decreased in 
AUD-like mice relative to low-risk mice.  To further validate this finding and determine 
whether ethanol drinking in a low-risk phenotype alters NMDA/AMPA ratio relative to 
ethanol-naïve animals, we replicated the experiment with an additional ethanol-naïve 
handling control and found that ethanol drinking alone reduces NMDA/AMPA ratio 
relative to ethanol naïve animals.  These data indicate that even moderate amount of ethanol 
consumption may be enough to alter glutamatergic synaptic plasticity mechanisms.  
The findings in this dissertation are the initial investigation of whether acute and 
chronic ethanol exposure modulates synaptic transmission in the INS.  The findings, on the 
whole, indicate that the glutamate system in the AIC is sensitive to ethanol, and that 
NMDAR-dependent signaling mechanisms in the AIC are sensitive to ethanol.  These 
investigations together with the prior literature provide two crucial points: That the INS 
regulates ethanol intake, and that the INS and its activity are directly modulated by ethanol.  
Therefore, the INS and its circuitry should be considered in the context of future 
investigations, and potentially in the context of AUD treatment targets.   
It is important to note that it has not yet been demonstrated whether ethanol’s action 
on the INS contributes to how the INS regulates ethanol intake.  Amongst other phenomena, 
Jaramillo and colleagues found that reducing activity in the INS substitutes for the 
discriminative stimulus/interoceptive effects of ethanol (Jaramillo et al., 2016).  Our data 
have shown that of the components of basic GABAergic and Glutamatergic transmission, 
NMDARs are sensitive to acute ethanol.  Therefore, since NMDARs are excitatory 
receptors which are inhibited by ethanol in the INS, and that reducing the activity of the 
INS substitutes for the interoceptive effects of ethanol, the most parsimonious hypothesis 
is that the actions of ethanol on NMDARS in the INS produces, at least in part, the 
discriminative effects of ethanol.  Future investigations of NMDARs in the INS and ethanol 
drinking are warranted. 
The recent development of techniques over the past decade that permit 
manipulation of in vivo brain function in a cell-type and/or circuit-specific manner may 
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have translational potential.  One of these techniques, Designer Receptors Exclusively 
Activated by Designer Drugs (DREADDS), entails virally expressing mutated G protein-
coupled receptors in brain cells of interest.  The expression of these mutated G-protein 
coupled receptors allows for the selective activation or inactivation of brain cells of interest 
by an otherwise inert ligand, clozapine N-oxide (CNO).  To date, DREADDS have been 
used to control neuronal activity in the brain, and investigate various aspects of psychiatric 
diseases, including several animal models of aspects of AUD (Cheng and Wang, 2019).  It 
is therefore conceivable that DREADDS may have efficacy treating psychiatric illnesses 
such as AUD.  DREADDS have already been safely expressed in nonhuman primates to 
modulate brain function and behavior (Eldridge et al., 2016).  Moreover, the most common 
viral approach to expressing a DREADD in the brain, an adeno-associated virus, is already 
approved for use in humans in gene therapies (Eldridge et al., 2016; Nagai et al., 2016; 
Pignataro et al., 2018).  Therefore, it is possible that DREADDS could be used in lieu of 
current FDA-approved invasive psychiatric techniques such as deep brain stimulation once 
precise targets for psychiatric disorders are elucidated by preclinical research.  
AUD is a multifaceted condition characterized by problematic preoccupation with, 
consumption of, and recovery from ethanol.  One of the subjective aspects of AUD which 
has gained recent interest to the addiction research community is craving.  Craving has 
recently been included as an AUD diagnosis criterion in the most recent iteration of the 
Diagnostic and Statistical Manual of Mental Disorders, the DSM-V (2013).  This inclusion 
is empirically supported, as craving has proven to be associated with severity of AUD, and 
relapse to drinking following treatment (Chakrovorty et al., 2010; MacKillop et al., 2010; 
Ramo & Brown, 2008; Zywiak et al., 1996).  In addition, craving has proven to be valid as 
a diagnostic criterion for AUD as well, as craving has shown to be positively corrected 
with indices of drinking, and adverse consequences of alcohol abuse (Murphy et al., 2014).  
The inclusion of a subjective craving component of AUD adds an additional impetus to 
elucidating the neurobiological substrates underlying ethanol craving.  Research from 
human and rodent laboratories indicate INS activity is involved in components of drug and 
ethanol craving and relapse behavior (Naqvi and Bechara 2010; Pushparaj and Lefoll, 
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2010; Venniro et al., 2017).  A more complete understanding of INS circuitry and cell-type 
specific involvement in cue-induced craving may have therapeutic potential.  A common-
sense, if not overly simplistic idea, would be a thorough characterization of INS cells 
involved in cue-induced craving.  Virally expressing either an inhibitory or excitatory 
DREADD into these cells (depending on how the disease state alters their function) could 
be a final safety net for individuals with AUD.  Oral CNO could be taken prophylactically 
before the individual goes into situations in which previous ethanol cues, are readily 
available and likely to cause cravings. 
The discoveries in this dissertation provide the first direct evidence of ethanol on 
AIC synaptic transmission and plasticity.  Interoceptive processing has recently gained 
appreciation as a vital, under-investigated component of the addiction cycle.  Therefore, 
future investigations of the INS are warranted. 
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